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Abstract
Background: Multiple internal and external factors are responsible for the development
and progression of chronic obstructive pulmonary disease (COPD). Noxious stimuli such
as cigarette smoking and other air borne pollutants set off the ongoing inflammatory
process of COPD resulting in air flow limitation and lung tissue destruction.
Objectives: Examination of inflammatory mediators of COPD and risk factors that
coincide with hospital admission for AECOPD. The aim of this dissertation was to
conduct a feasibility study to implement an educational intervention for hospitalized
patients and evaluate their quality of life (QOL), using the RE-AIM framework to
evaluate outcomes.
Design: This dissertation includes three papers: a principle-based concept analysis on
inflammatory mediators related to COPD, an integrative review of the psychometric
instruments used to measure risk factors for hospitalization among patients with COPD,
and a feasibility study using the American Lung Association’s modified COPD Action
Plan to instruct patients with COPD on identifying early signs of an exacerbation and
when to seek medical care. In addition, quality of life perceptions were evaluated using
the World Health Organization-BREF (WHOQOL-BREF) before hospital discharge and
30 days post discharge via phone call.
Conclusions: COPD is a complex chronic disease with an insidious onset by
inflammatory mediator(s) or genetic origin. The episodic acute exacerbations of COPD
(AECOPD) are responsible for high healthcare utilization and perceptions of low quality
of life. The feasibility study results suggest implementation of the American Lung
Association modified COPD Action Plan can be carried out as discharge instructions and
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QOL evaluated using the WHOQOL-BREF questionnaire. Positive ratings and
comments on the delivery and content of the COPD Action Plan were found in a small
sample of participants who responded to follow up.

  

x  

Introduction
Chronic obstructive pulmonary disease (COPD) is one of the most common
chronic diseases in the United States (US) with approximately 13.6 million individuals
diagnosed with COPD and an equal number undiagnosed (Healthy People 2020, 2012).
The physical, psychological and economic burden of living with COPD negatively affects
quality of life (QOL) of patients and their caregivers. COPD is the third leading cause of
death in the US, and management of the disease remains suboptimal (National Institutes
of Health, 2013).
Due to complex ongoing inflammation, COPD is a progressively deteriorating
lung disease. Ongoing exposure to noxious sources of inhalational irritants from cigarette
smoking, occupational exposures, and outdoor air pollution perpetuate an inflammatory
cascade and ultimately lead to airway airflow limitation (Barnes, 2016). COPD is an
insidious respiratory disease due to chronic and acute episodes of inflammation.
Acute exacerbation of COPD (AECOPD) is defined as acute flares of
inflammation that frequently lead to hospitalization for patients with COPD. Risk factors
involving hospitalization for patients with COPD include: comorbidities, past
hospitalizations, low forced expiratory volume in one second (FEV1), socioeconomic
status (urban and rural), physical functional ability (ambulating, bathing and dressing),
psychological aspects of anxiety, and depression impacting QOL (American College of
Chest Physicians, 2012; Conley & Gregoski, 2015). AECOPD is the third most common
cause of hospital readmissions within 30 days post discharge. The incidence of
recidivism is likely to occur in patients with comorbidities or those with more serious
COPD disease (Panettieri, 2013).
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For both patients and the health care system, there is tremendous financial
responsibility, with an estimated $50 billion spent annually in consumption of health care
resources and other costs due to work absences (American College of Chest Physicians,
2014; Jalota & Jain, 2016; Jennings et al., 2014;). Complicating matters, approximately
20% of individuals discharged from US hospitals are readmitted within 30 days (Centers
of Medicare and Medicaid, 2014), and Centers of Medicare and Medicaid (CMS)
withhold compensation to hospitals for these readmissions, costing an average of
$130,000 to each US hospital. A more effective chronic care management process is
critically needed by the US acute care system (Centers of Medicare and Medicaid, 2014;
Polster, 2015).
This dissertation is composed of three papers that link the complex etiology of
inflammation in COPD to the risk factors among individuals hospitalized with COPD and
the need for an educational intervention. Potentially, an educational intervention could
reduce morbidity and mortality and improve perceived QOL. The first paper is a
principle-based concept analysis that examines inflammatory mediators involved in
triggering the onset and chronic progression of inflammation in COPD. The paper
highlights the risks of being exposed to external factors (indoor, outdoor pollution, and
smoking) and internal factors (aspects related to the inflammatory process and genetics)
responsible for COPD exacerbations (Barnes, 2016). This concept analysis of what
causes inflammation in COPD by inflammatory mediators is a stepping stone to
understanding the acute exacerbations of COPD (AECOPD). The paper has been
accepted for publication.
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The second paper, which has been published, is an integrative review of the risk
factors associated with hospital admission related to COPD and highlighted the need to
assess patients with COPD for the risk of readmission (Conley & Gregoski, 2015).
Examining the best methods to measure risk factors for developing COPD complications
leading to hospital readmission, as well as assessing for QOL perceptions of patients
hospitalized with COPD, is essential to improving care and QOL for these patients.
Therefore, it was determined that a concise instrument is needed to assess risk factors for
hospital admission of patients with COPD (Conley & Gregoski, 2015; Kansagara et al.,
2011).
The concept analysis of inflammatory mediators and integrative review of risk
factors for hospitalization among patients with COPD served as groundwork for the
dissertation study. Consequently, the third paper is from the dissertation study, which
investigated an education model prior to discharge. The goal of this study was to educate
hospitalized patients with COPD to recognize early changes in their condition.
Accordingly, learning to identify changes at the onset, most times, signals the need to
contact a medical provider or to seek more advanced medical care in order to prevent
further morbidity and mortality of recurrent COPD acute exacerbations. The study
evaluated the feasibility of implementing the American Lung Association (ALA) COPD
Action Plan to provide an individualized, disease specific discharge education to patients
with COPD and evaluate QOL using the World Health Organization-BREF (WHOQOLBREF) (ALA, 2013; WHOQOL-BREF, 1997). Distinctly, the goal was to increase
patients’ knowledge of changes in respiratory symptoms and related effects of COPD and
of when to seek prompt medical care. Such knowledge may decrease occurrences of
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AECOPD and hospital admissions of patients with COPD, as well as improve QOL
perceptions by participants (Choi, Chung, & Han, 2014; Mitchell et al., 2016).
A structured action plan, delivered individually, may help overcome obstacles to
teaching patients with COPD, many of which are related to the diverse needs and
backgrounds of patients, making it essential to deliver discharge instructions one-to-one,
nurse to patient (Hanania, 2012; Sheppard et al., 2013, Polster, 2015). Also, it is
common for patients with COPD to experience anxiety and depression related to
breathlessness episodes and decreased functional abilities that impair perceptions of QOL
(Coventry, Gemmell & Todd, 2011; Ries, 2006). As a result, the modified COPD Action
Plan was selected because it is a concise format for educating patients on selfmanagement and symptom control, and because it has an easy-to-understand format. The
instructions are organized in color zones to illustrate how patients should self-assess how
they feel, ranging from good day (green), bad day (yellow), and when there is an urgent
need for medical care (red). Thus, the plan highlights the need to promptly act on
changes in symptoms that signal the need to contact or seek professional health care
(American Lung Association, 2013; Effing et al., 2012). Additionally, this plan is
familiar to pulmonary medical providers due to the widespread use of these types of
asthma action plans. Next, QOL before and after discharge from the hospital was
measured with the WHOQOL-BREF. The WHOQOL-BREF was selected because it is a
reliable and validated instrument with 26-items measuring physical, psychological,
social, and environmental domains (Skevington, Lofty & O’Connell, 2004).
To measure feasibility of this discharge clinical procedure, the Reach,
Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) framework was
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used to evaluate delivery of the action plan as a discharge teaching tool via the 30 day
follow up phone call after discharge (Glasgow, Vogt & Boles, 1999). Reach included
recruitment and retention of the sample population of participants with COPD
hospitalized on a Progressive Care Unit (PCU). Effectiveness was measured by outcome
of the participants’ perception of benefit of the COPD Action Plan based on a 30 day
follow up survey and qualitative results. PCU nurse completion of a questionnaire on
perception of benefit involving the discharge intervention to participants with COPD was
evaluated. The survey completed by a PCU nurse was used to evaluate acceptance and
feasibility by the PCU nurse trained to instruct participants on the COPD Action Plan.
Adoption was evaluated by PCU nursing staff (rated responses) and participants’
perception of willingness to adopt the discharge clinical procedure (rated responses, 30
day outcomes of health care utilization and QOL outcomes). Implementation of the
clinical procedure was appraised by consistency in delivery (fidelity) of the COPD
discharge procedure assessed by observation and based on feedback from participants
and the nurse’s recommendations. Maintenance of the discharge procedure for patients
with COPD (survey and qualitative results) to be used hospital-wide will be determined
following completion of this study (Carnerio et al., 2010; Glasgow, Vogt & Boles, 1999).
Overall, the long term objective of this dissertation study was to, first, provide a
specific strategy to address the educational needs of patients with COPD in the acute care
setting and, second, identify issues of participants that are associated with their QOL
(National Institute of Nursing Research, 2013; Scott, Baltzan, Dajczman, & Wolkove,
2011). Evidence suggests that reducing dyspnea or improving ways to cope with
breathlessness, such as learning pursed lip breathing, improves QOL (Feldman, 2013).
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Additionally, support networks by phone or online help patients cope with anxiety and
depression. Future studies should address ways to teach patients to conserve their energy
that could potentially improve perceived QOL related to impaired activity tolerance from
dyspnea.
Research Question
What is the outcome of using the American Lung Association COPD Action Plan
in terms of self-rated knowledge and assessment of QOL in a cohort of patients
discharged from a Progressive Care Unit after hospitalization for an AECOPD or COPD?
Gaps in Knowledge
Based on a review of the literature, research evidence is limited regarding
outcomes of specific patient education instruments delivered during hospitalization and
evaluating QOL (Almago & Castro, 2013; Mularski et al., 2012). Compared to COPD
action plans, action plans for asthma have been studied more extensively for their
educational impact on respiratory symptoms and self-management outcomes. Jalota and
Jain (2016) report that 400 asthma action plans have been investigated as to their
effectiveness in teaching self-management of symptoms compared to 69 studies on
COPD action plans. Their findings on asthma action plans indicated effectiveness in
prevention of more severe asthma exacerbations. COPD action plans may be beneficial to
patients in acquiring knowledge, increasing confidence in managing their lung disease,
and making decisions when to contact health care providers.
Few studies have evaluated the most effective evidence-based action plans that
teach specific self-management to guide discharge education for hospitalized patients
with COPD. Further evidence is needed on outcomes of improved self-management,
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such as through early recognition of symptoms, prompt medical care, reduced hospital
readmissions, and improved perceived QOL post discharge (Bischoff et al., 2011; Effing
et al., 2012; Jennings et al., 2014). Sunde et al. (2014) implemented a prospective
clinical intervention study using a multidisciplinary COPD-Home model to teach
individualized self-management skills and provide support from other health care
professionals. Also, Sunde et al. (2014) described the outcome strengths of the model
being integrated care and continuous reinforcement of self-management skills to improve
COPD. Sunde and colleagues pointed out that evidence is needed to support
effectiveness and impact on QOL (Sunde et al., 2014). Moreover, given obstacles to
teaching patients with COPD, many of which are related to the diverse needs and
backgrounds of patients, it is essential to deliver individually tailored discharge
instructions (Hanania, 2012; Polster, 2015; Sheppard et al., 2013).
Using a COPD self-management education plan for outpatients in a prospective
study, using a parallel group, by Labrecque et al. (2011) found a decrease in emergency
department (ED) visits measuring participants per year (p = 0.002). In addition,
hospitalizations were reduced (p = 0.17). Researchers attributed the nonsignificant result
to the specific definition of ED visits being 24 hours or less, and improved health-related
quality of life (HRQOL) in patients with COPD at 12 months (p < 0.001). Scott and
colleagues (2011) compared knowledge of COPD and information needs of outpatients
and in hospital patients with COPD using two questionnaires. Reported results showed a
positive correlation between prior COPD learning and high school education (p < 0.05).
Also, a positive correlation was found from prior COPD instructions and lower Lung
Information Needs Questionnaire (LINQ) score (p < 0.01) (Scott et al., 2011).
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Researchers Choi, Chung, and Han (2014) conducted a cross-sectional descriptive study
on outpatients in a COPD clinic and found adherence to an action plan reduced
unplanned hospitalizations (p = 0.001).
Trappenburg et al. (2011) conducted a multicenter randomized controlled trial on
outpatients, to test the effectiveness of administering personalized COPD action plans to
reduce exacerbation recovery time and every three days completed the Clinical COPD
Questionnaire (CCQ) to measure health status. Their results based on the CCQ scores
indicated above the minimal pertinent difference 0.4 points (p </ 0.01) (Trappenburg et
al., 2011). Other researchers carried out a randomized controlled trial to assess the
impact of a comprehensive intervention for patients with COPD discharged from the
hospital (Ko et al., 2016). What the researchers found, based on the intervention group,
was a reduction in hospitalization for AECOPD (p = 0.047) and decreased length of stay
(LOS) (p </ 0.001) (Ko et al., 2016). Ko et al. (2016) were not able to provide evidence
as to what particular intervention was most effective.
Furthermore, Krishnan and researchers found that multidisciplinary educational
action programs, not disease specific, included evaluation of QOL, physical exercise, and
follow up phones calls to patients after discharge, decreased hospitalizations (Krishnan et
al., 2015; Nelson & Pulley, 2015). In addition, findings were investigated from
comprehensive discharge programs that bundle interventions (education, exercise, and
follow up phone calls after discharge) such as Project Better Outcomes through
Optimizing Safe Transitions (BOOST) for COPD patients. Results showed improved
outcomes, fewer hospitalizations, and increased QOL. Mularski et al. (2012) examined
comparative effectiveness research for patients with COPD. They called for collaboration
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among researchers, clinicians, payers, and policymakers in broadening methodologies
such as repeating performed effectiveness designs that examine longitudinally over time
positive and negative outcomes, as well as expense (Mularski et al., 2012).
In summary, the findings point to a need for conformity of a statistically proven
effective COPD discharge instructions delivered (either written, audiovisual, or electronic
tablet-based) to improve self-management among patients with COPD (Choi et al., 2014,
Mularski et al., 2012; Sawyer et al., 2016; Schafer et al., 2015). Future studies are
needed that detail implementation, content of instructions, and are individualized based
on assessment of prior participant knowledge of self-management and evaluation of
QOL. (Effing et al., 2012).
Design and Method
The study took place on a 24-bed Progressive Care Unit (PCU) at an urban
hospital. Descriptive statistics will report the demographic data and participant
characteristics. The Wilcoxon signed-ranks test will be used to compare QOL domain
scores of participants before hospital discharge and again from the 30 phone call
reevaluation of QOL. Qualitative data was obtained from the participants during the 30
day call back which was pulled out from open ended comments. These comments were
read and reviewed with my qualitative mentor and the prevailing themes were
categorized.
Theoretical Framework
Socio-Ecological Model (SEM) was used to guide the paper involving risk factors
for hospitalization of patients with COPD and development of the structured discharge
educational protocol and QOL evaluation. Application of SEM for the feasibility study
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was appropriate because it recognizes the interconnectedness in layers of influence for
patients with COPD (Centers for Disease Control and Prevention, 2015). The framework
consists of multiple levels of influence which include: the individual, their knowledge,
motivation and skills; interpersonal relationships that consists of, family, friends and
social network; organizations, involving environmental factors such as air pollutants
indoors and outdoors, smoking first hand or second hand. In addition to community
resources composed of connections and support between organizations in the community,
and home. Public policies embody the laws to support and protect individuals and
communities (CDC, 2015). The SEM provided a relevant framework to create an
educational solution to instruct critically ill hospitalized patients with COPD on selfmanagement skills to identify and manage respiratory symptoms as well as to evaluate
their perceptions of QOL.
Conclusion
This dissertation explored the concept of inflammation using a principle-based
concept analysis to examine inflammatory mediators related to the onset of chronic and
acute inflammation in COPD. The concept analysis of recent findings involving
inflammatory mediators revealed that further investigation is needed, in order to clearly
define the triggers to inflammation. Furthermore, research is essential to discover what
preventive measures or pharmacological antagonists to inactivate the triggers involving
inflammation in COPD.
The second paper describes the psychometric measurements that have been used
to determine how best to identify and predict patients with COPD who are most at risk
for AECOPD that results in hospitalization and rehospitalization, especially within 30
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days following discharge for the same. Clearly, this integrative review illustrated how
many studies used several instruments to assess risk factors for hospitalization among
patients with COPD. Rational for using numerous measurements to determine risk
factors for hospital admission was attributed to the multifactorial entity of COPD that
includes severity of disease, psychosocial, and socioeconomic factors of each individual.
Producing a valid and concise instrument to pin-point at risk patients with COPD for
hospital admission in the critical care setting would be valuable.
Culmination of the principle-based concept analysis paper on inflammatory
mediators in COPD and integrative review of risk factors for hospitalization for
AECOPD among patients with COPD was the premise for the structured discharge
feasibility study. This study was designed and conducted to examine delivery of the
modified ALA COPD Action Plan, assess QOL using the WHOQOL-BREF, and
evaluate outcomes using the RE-AIM Framework. Recruitment of the goal sample
population was met, but possible barriers to retention of participants in the 30 day follow
up that was low, which could be attributed to lack of compliance and socioeconomic
barriers. Adoption was evaluated by the participant and one trained PCU nurse
responses, which was limited due to the small follow-up sample (n =13).. The
participants, who were reached via phone call on the 30 day follow-up, reported low
healthcare utilization which may indicate gained knowledge of taking their prescribed
respiratory medication and keeping scheduled appointments after hospital discharge.
There was no difference in scores taken in hospital and 30 day follow-up by phone using
the WHOQOL-BREF, calculated with the Wilcoxon signed-ranks test. The WHOQOLBREF has documented reliability and validity, but for this critically ill patient population,
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it was imperative for the PI to read and record the answers for the participants.
Implementation in the delivery of the COPD Action Plan to participants was feasible
based on the response from the PCU nurse and the PI. Taking the strengths from the
outcomes of this feasibility study, the PCU clinical manager approved use of the
modified ALA COPD Action Plan as discharge instructions for patients with COPD.
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Abstract
Aim: To report a principle-based concept analysis of inflammatory mediators related to
chronic obstructive pulmonary disease (COPD).
Background: In patients with COPD, acute and chronic inflammation within the
bronchi cause luminal narrowing from mucosal edema, smooth muscle contraction and
mucus production that contributes to gas exchange impairment. Shortness of breath and
limited exercise tolerance are common symptoms of COPD. The mediators that trigger
acute inflammatory responses and perpetuate chronic inflammation in COPD have been
investigated on a molecular, cellular, and global physiologic level. The exact mediators
of inflammation have not been conclusively determined.
Design: Principle-based method of concept analysis.
Methods: Systematic review of the literature in 2015 using the MeSh words
“pulmonary disease, chronic obstructive” AND MeSh words “inflammation mediators”
in only English were searched in PubMed, CINAHL, Cochrane, Medline and Google
Scholar.
Results: The concept of inflammation continues to evolve. There are now numerous
inflammatory mediators linked to COPD. Four principles are used to conduct the
concept analysis of inflammation in COPD: linguistic, logical, epistemological, and
pragmatic. The final analysis retained 15 articles.
Conclusions: This paper provides insight regarding the concept of inflammation within
COPD by developing epistemology on the exact factor(s) triggering inflammation. The
global impact of this debilitating disease and high level of health care utilization calls
for a collaboration among health care providers and researchers.
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Relevance: Nursing has a pivotal role in caring for patients with COPD and conducting
research on mediators of inflammation related to COPD. Further research is needed to
discover definitively mediators that perpetuate of this serious lung disease in order to
improve outcomes. Such outcomes would identify the prevention strategies and develop
treatments that could better target the detrimental effects of this inflammation.
Keywords: COPD lung inflammation, pulmonary disease, chronic obstructive and
inflammation, inflammatory mediators of COPD
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Introduction
Inflammation has a historical and scientific background related to lung
inflammation which can best be understood using the lens of the principle-based
concept analysis. A documented history identifies and describes inflammation dating as
far back as 2000 years ago. Medzhitov, a professor of immunology, defined
inflammation as a process triggered by tissue injury or infection, which elicits the
recruitment of plasma proteins and leukocytes to the affected site.1 Having knowledge
of the phenomenon involving inflammation for nurses is necessary due to the impact on
many aspects of providing care (teaching patients avoidance of precipitating factors),
education (instructing patients on prescribed anti-inflammatory medications), and
research (for evidence-based practice). Therefore, evidence-based knowledge, regarding
causes related to the altered inflammatory process involving COPD that results in air
flow limitation, is essential for health care professionals.2 Understanding the science
identifying the triggers of mechanisms causing inflammation associated with COPD can
be translated to the importance of avoiding pollutants. Sources of pollutants can
include: being a smoker or exposure to second hand cigarette smoke, occupational,
indoor, or outdoor sources. Other sources encompass being in close proximity to
industrial or high traffic areas, or during times there are high ozone alerts. 1-3
The principle-based concept analysis is a blueprint to build on the clinical
understanding of inflammation for the underpinning of professional nursing practice
and other health care professionals. Penrod and Hupcey’s four principles:
epistemological, pragmatic, linguistic, and logical will be used to assess the level of
maturity for the concept of inflammation.6 While inflammation is on one hand
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beneficial, as in the process of wound healing, it can be detrimental when it causes
swelling in bronchial tubes making breathing and air exchange difficult.7 Over time,
chronic inflammation leads to destruction in the lung tissue results in COPD. In health
care, timely and accurate identification of an acute exacerbation of COPD (AECOPD)
involving an acute inflammatory response is critical. AECOPD occurrences causes
more frequent coughing with many times increased production of sputum, worsening
activity tolerance related to difficulty breathing, and further dyspnea (breathlessness)
could ultimately result in respiratory failure (Global Initiative for Chronic Obstructive
Pulmonary Disease (GOLD).8 The seriousness of COPD is documented by the National
Institutes of Health as being the third leading cause of death in the United States and the
fourth leading cause of death globally.7, 9-11
Background
Inflammation has been poignantly referred to as the old flame, but without the
actual fire. This means that inflammation can cause similar pain and discomfort as a burn,
but not be caused by an actual burn from a fire. The term ‘edema’ carries over to today
as being part of a common descriptive involving inflammation that began with
Hippocrates in the 5th century BC, in which he described edema being part of the healing
process following tissue injury.12 During the 1st century, Celsus, a Roman encyclopedist,
defined the four signs of inflammation with the terms: “rubor, et tumor cum calore et
dolore” meaning redness and swelling with heat and pain (p. 958).13 A fifth component
was added by a Greek physician Galen, to the signs of inflammation, “function laesa”
that described  impaired function of an affected extremity (p. 104).14 Elie Mechnikoff, a
zoologist, discovered the outcome in “leukocyte recruitment and phagocytosis of
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microorganisms involving human protection against inflammation, infection, and
immunity” (p. 3257).15 This finding propelled the understanding of inflammatory process
for treatment.1,15 Scott et al. pointed out that the definition of inflammation has
dramatically changed since the origin of its use almost 2000 years ago.16 Currently, the
meaning of inflammation is determined by how it is assessed “clinically, microscopically
at the cellular or molecular level” (p.248).16
Inflammation related to COPD is manifested in several forms. The onset of
COPD is most commonly a progressive form that is insidious and continuous, as
compared to the critical manifestation that occurs in acute exacerbations of COPD
(AECOPD). The first form of inflammation contributes to the ongoing downward spiral
of worsening restrictive air flow condition in the lungs. In the acute form, the impact to
the pulmonary system is so severe that most patients do not fully recover. The concept of
inflammation is knowingly linked to physiological mediators responsible for COPD, but
they are still not completely understood. There is heterogeneity in the scientific evidence
for mediators as the culprit for the abnormal inflammatory pathophysiology in COPD.17
Data sources
A review of the literature was performed to carry out the principle-based concept
analysis of inflammation which produced information on the scientific findings
pertaining to mediators for inflammation in patients with COPD. Multiple data base
search engines were used to obtain articles related to inflammatory mediators in COPD.
PubMed, CINAHL, Google Scholar, Cochrane via EBSCO interface, and Medline via
EBSCO interface was searched using the following MeSH terms: “pulmonary disease,
chronic obstructive” AND MeSH terms “Inflammation-Mediators.” Inclusion criteria
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and results from each data base: adults, adults with COPD, mouse models examining
causes of inflammation related to COPD. Exclusion criteria included pediatric studies
and those delivering treatments or interventions for lung inflammation.
A systematic review was conducted to obtain studies for use in the principlebased concept analysis which included 15 articles in the final data set. Abstracts were
reviewed and study types ranged from those having adult humans and mouse models.
Antecedents
A concept analysis of inflammation requires an understanding involving the
antecedents of inflammation. Antecedents of inflammation in COPD involve a precursor
or stimulus from which an individual is exposed to such as cigarette smoke first hand,
second hand, or some type of air pollution. The stimulus in most cases is the trigger for
mediators that set into motion the detrimental inflammatory activity, described by the
Latin term “inflammare (to set on fire)” the Latin term.16
Attributes
The characteristic attributes of inflammation include: redness, warmth,
swelling, pain, and limited function.18 For COPD, chronic inflammation is
attributable to breathlessness especially on exertion and poor activity tolerance. In
an AECOPD, an individual can exhibit some of the following clinical signs and
symptoms of increased difficulty breathing (dyspnea) or breathlessness, increased
frequency of cough, productive cough with colored sputum (yellow, green or
sometimes blood tinged).7 Moreover, building on the historical roots of
inflammation, its antecedents as well as the attributes, we gain an understanding
when conducting an assessment of a patient’s respiratory function. Classification of
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airflow limitation in COPD individuals is measured by spirometry that calculates
the volume of air an individual can exhale from their lungs following a maximum
inspiration.8 The Global Initiative for COPD established the measurement of
forced expiratory volume in one second (FEV1) being less than 70% as a marker of
COPD.8 Table 1.
Linguistic principle
To fulfill the linguistic principle, a concept needs to have consistency in its use
and meaning.6 Therefore, from the analysis of the linguistic principle the meaning of
inflammation found in COPD is used consistently throughout the literature, in that it
results in air flow limitation.19 Scientific evidence is not uniform surrounding the
physiological process of mediators attributable to the dysfunctional inflammatory process
in COPD. Irregularity exists in the evidence on mediators of how they cause acute
exacerbations of COPD and the chronic progression of the disease, is still being
investigated. Table 2. The literature reflects how empirical measurements have evolved
in an effort to establish uniformity in quantifying the symptoms that are a consequence of
inflammation. Calculating the degree of severity involving airflow limitation, as
described by GOLD, is an indirect quantitative measurement that reflects the effects of
inflammation. GOLD employs a classification of COPD severity ranging from mild to
severe. Mild COPD is classified as forced expiratory volume in one second (FEV1)
“post-bronchodilator use >/ 80% predicted to severe FEV1 <30% predicted” (p. 9).8
Use of a standardized instrument that has a scale with clinical descriptions to
quantify clinical features of patients having respiratory difficulty would promote
distinctions in severity of respiratory distress. Such a standardized instrument to assess a
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patient in the acute and critical care setting would be valuable. Being able to rate the
severity of dyspnea could add to the objectivity of a respiratory assessment of patients
with COPD, especially for patients who are unable to describe their symptoms due to
altered cognition or effects of hypoxia or hypercapnia.20
Logical principle
A concept is logical if it maintains its framework within the limits of theory
application.6 Sources in the literature cited external inflammatory factors from cigarette
smoking to ozone levels. What the literature confirmed to be uncertain was that various
precipitating pathophysiological sources elicit a variety of identified mediators. Some
mechanisms identified to be accountable for inflammation in COPD include the alteration
in Sirtuin1 Protein Coding gene in the circadian molecular clock rhythm of cigarette
smokers.21 Other researchers found proteases in agricultural dust from enclosed animal
feeding sites and household mite dust to be mediators.4 Consistently, the literature cited
external inflammatory factors being predominately cigarette smoking as the most
common noxious stimuli eliciting cellular and molecular mechanisms responsible for
inflammation found in COPD.22-24 Barouchos et al found tumor markers were related to
inflammation of COPD and the degree of disease severity.25 Haw and colleagues
reported from their research an increase in tumor necrosis factor-related cell selfdestruction (apoptosis) induced ligand (TRIAL), a cytokine to be the key in the abnormal
inflammatory pathology in COPD.26 Other researchers found exposure to cigarette
smoking resulted in an abnormal reaction of causing an increase in Tc17 cells which
scientists related to inflammation related to COPD.27
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Another study identified pathogenic microorganisms in sputum to be linked to
inflammation in COPD.5, 28 Increased levels of pigment epithelium-derived factor
(PEDF) correlated with inflammation involved in COPD and decreased FEV1.29 Other
studies revealed the amount of progranulin in sputum, the loss of glycerol dehydratasepositive Lactobacilllus, and nuclear factor kappaB as factors related to lung inflammation
in COPD.30-32 In addition, it has been found that precipitating sources such as ozone air
pollution elicits a variety of identified mediators that can cause an alteration in circadian
rhythm. This disruption in the circadian rhythm was found by researchers which resulted
in a cascade reaction from pro-inflammatory mediators causing inflammation in COPD.3
Therefore, identification of which specific mediators of inflammation are responsible and
how the process becomes ongoing and acute in COPD would help enable development of
more effective treatment.8, 33
In particular, critically ill hospitalized adults with COPD are a vulnerable
population who depend largely on the nurse and medical staff when it comes to
identification on potential causes of an ECOPD. Causes of ECOPD can range from
infection, an external source (smoke or air pollution) in the environment, or an acute
progression of the disease. No theoretical framework specific to mediators signaling
inflammation causing COPD was found in the literature. Theories that are available
focus on the care of symptoms and functional disability subsequent to COPD. Coleman
et al. addressed the use of the Chronic Care Model with its aim to improve patient to
physician and nurse relationship for better patient outcomes.34 Nursing’s essential role in
care of these patients encompasses carrying out interventions, education, and
reassessment of outcomes. These aspects are important in order to promote health
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through prevention (avoidance of noxious airborne pollutants), recovery when there are
exacerbations, and to help reduce severity of ECOPD as well as further decline in their
pulmonary status.
Epistemological principle
A concept that has a sound epistemological principle is clearly defined and
discernible from other concepts.6 Inflammation, as a concept related to COPD, is defined
as chronic inflammation of airways and lung tissue that alters gas exchange.35
Characteristic clinical features that can be indirectly measured and described, including
dyspnea, cough, and limited activity tolerance. The degree of COPD severity can be
graded as established in guidelines by GOLD.8 Clinical features such as air flow
limitation that define COPD are also shared by other pulmonary diseases. Air flow
limitation is also present in asthma, cystic fibrosis, and constrictive bronchiolitis.36 The
mediators(s) that is responsible for air flow limitation among these pulmonary diseases is
what is different. Distinctly, impaired air flow limitation creates shortness of breath and
decreased activity tolerance.37 In COPD, there is no definite set of mediator(s) that can
be pinpointed as being attributable to the abnormal inflammatory process.
Shortness of breath also referred to as difficulty breathing or breathlessness is
common attribute of COPD. Some patients describe these acute episodes of shortness of
breath as near death experiences.38 Others have made an effort to quantify the degree of
shortness of breath. One instrument that patients can rate their level of shortness of breath
is the Borg scale that gives patients a range of 0 to 10, with 0 being no effort in breathing
and 10 maximal feeling of difficulty breathing.17
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Impaired functional endurance in patients with COPD is another predominate clinical
attribute. Decreased activity tolerance impacts individuals with COPD in their ability to
ambulate, do grocery shopping, and as the disease progresses getting to the bathroom or
kitchen become a major hurdle. Two measurements of shortness of breath include the
Borg visual analog scale that scores level of dyspnea from 0 (none) to 10 (severe).39
Another instrument to measure activity tolerance includes body mass index, degree of
air flow obstruction and dyspnea, and exercise capacity index (BODE).40
Pragmatic principle
The concept needs to be relevant in the realm of scientific inquiry in order to fulfill the
criteria for the pragmatic principle.6 Here the concept of inflammation is known to be a
process that occurs as a result of infection, tissue injury from various airborne noxious
stimuli, or para-inflammation that is likely responsible for autoinflammatory diseases.1
Most currently cellular and molecular mediators are being found as the culprit of
inflammation found in COPD. In the disease process of COPD, inflammation is defined
for what it is; abnormal and chronic, with acute episodes involving the peripheral
airways and lung parenchyma.19 Additionally, to fulfill the pragmatic principle, a
concept must be well-operationalized, in that it can be measured. Therefore, to examine
the consequences of inflammation involving COPD, indirect measurements can be
obtained by using the following parameters: results of arterial blood gases, pulse
oximeter readings, observational assessment for degree of respiratory distress, activity
tolerance, and level of consciousness. Inflammation in COPD is not completely a
mature concept since at this time the responsible mediators that trigger the inflammatory
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process are not all completely understood. Also, there are a lack of universal standards
to measure inflammatory mediators, based on the evidence found in the literature.
Results
This paper uncovers the gap of what mechanisms are responsible for the chronic
and acute inflammatory process related to COPD. Oh and Sin proposed that phenotyping
patients with COPD could help target which specific mechanisms are linked to an
individual’s cause of inflammation.19 Despite a multitude of different mediators reported
in the studies, the findings are not conclusive. The implications of external, internal
factors along with genetic implications play a role in mediators that malfunction causing
airway inflammation in COPD. Therefore, gaining knowledge of the mechanisms for the
inflammation process gives a deeper foundation to the concept of inflammation. Nurse
research scientists have a pivotal role in collaborating with other researchers in the
discovery of mechanisms in COPD inflammation, as well as treatment modalities.41 It is
important to recognize that the analysis of inflammation is fluid, since science is a
dynamic process with new discoveries in pathogenesis that can improve assessment and
treatment modalities for those with COPD.
Conclusion
The principle-based concept analysis provided a rigorous process to examine the
principles that comprise the concept of inflammation. No consistent theoretical definition
was found for mediators responsible for the abnormal inflammation in COPD. Each
principle was examined based on the empirical data found in the literature illustrating the
heterogeneous nature of mediators connected to the altered pathophysiology of
inflammation among patients with COPD. Emphasis on further scientific research is
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needed by nurses, physicians, respiratory therapists, and bench scientists to work together
in phenotyping individuals with COPD in order to identify the specific mediator(s)
eliciting and perpetuating the destructive inflammatory process. In the future,
phenotyping could be linked to treatments aimed at specific identified mediators which
could be more effective in slowing the chronic inflammation in COPD and helping to
prevent AECOPD occurrences.
Relevance to clinical practice
•   Identification of the attributes, antecedents, and outcomes of inflammation in
COPD is essential to the clinical practice of nurses caring for these patients. The
principle-based concept analysis of inflammation, as evidenced by various
mediators, is the foundation of further research.
•   A historical and scientific background provides a comprehensive framework to
problem solving of this debilitating lung disease that is an international health
burden. Nurses working together with other health care disciplines and scientists
have the potential to improve health care delivery and quality of life for
individuals with COPD.

  

29  

References
1.   Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008; 454,
428-435.
2.   Center for Disease Control and Prevention. 2015;
http://www.cdc.gov/copd/index.html
3.   Pirozzi C, Sturrock A, Weng HY, Greene T, Scholand MB, Kanner R. Effect of
naturally occurring ozone air pollution episodes on pulmonary oxidative stress and
inflammation. Int J Environ Res Public Health. 2015; 12(5), 5061-5075.
4.   Romberger DJ, Heires AJ, Nordgren TM, Souder CP, West WW, Poole JA et al.
Proteases in agricultural dust induce lung inflammation through PAR-1 and PAR-2
activation. Am J Physiol Lung Cell Mol Physiol, 2015; ajplung-00025.
5.   Tufvesson E, Bjermer L, Ekberg M. Patients with chronic obstructive pulmonary
disease and chronically colonized with Haemophilus influenzae during stable disease
phase have increased airway inflammation. Int J Chron Obstruct Pulmon Dis. 2014;
10: 881-889.
6.   Penrod, J, Huprey J. Enhancing methodological clarity: principle-based concept
analysis. J Adv Nurs. 2005; 50(4): 403-409.
7.   American Thoracic Society. Exacerbation of COPD. Am J Respir Crit Care Med;
2014; 189, 11-12, www.thoracic.org ATS Patient Education Series © 2014 American
Thoracic Society.
8.   Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for
the diagnosis, management, and prevention of chronic obstructive pulmonary disease.
2015; http://www.goldcopd.org
9.   NIH Fact Sheets. Chronic obstructive pulmonary disease (COPD). 2013;
http://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=77
10.  Mackay, AJ, & Hurst, JR. COPD exacerbations: causes, prevention, and treatment.
Med Clin North Am, 2012; 96(4): 789-809. doi: 10.1016/j.mcna.2012.02.008
11.  Schmidt SA, Johansen MB, Olsen M, Xu X, Parker JM, Molfino NA, et al. The
impact of exacerbation frequency on mortality following acute exacerbations of
COPD: a registry-based cohort study. BMJ Open. 2014; 4(12), e006720. doi:
10.1136/bmjopen-2014-006720
12.  Granger, D., & Senchenkova, E. National Library of Medicine, National Institutes of
Health. Inflammation and the microcirculation (NBK53379). 2010; California:
Morgan & Claypool Life Sciences. Chapter 2.
13.  Tedgui A. Focus on inflammation. Arterioscler Thromb Vasc Biol. 2011; 31(5): 958959. doi:10.1161/atvbaha.111.227355
14.  Heidland A, Klassen A, Rutkowski P, Bahner U. The contribution of Rudolf Virchow
to the concept of inflammation: what is still of importance? J nephrol. 2006; 19(Supp
10), 102-109.
15.  Gordon S. Elie metchnikoff: Father of natural immunity. Eur J Immunol, 2008; 38:
3257-3264.
16.  Scott A, Khan K, Roberts C, Cook J, Durano V. What do we mean by the term
"inflammation"? A contemporary basic science update for sports medicine. Br J
Sports Med. 2004; 38, 372-380.

  

30  

17.  Wang HY, Xu QF, Yuan W, Nie S, He X, Zhang, J et al. A new method for rating
dyspnea during exercise in patients with chronic obstructive pulmonary disease.
Chinese medical journal. 2013; 126(19), 3616-3620.
18.  Stedman’s Medical Dictionary, 2013, Retrieved from www.medilexicon
19.  Oh JY, Sin DD. Lung inflammation in COPD: why does it matter? F1000 Medicine
Reports, 2012; 4, 23. http://doi.org/10.3410/M4-23
20.  Campbell ML, Templin T, Walch J. A respiratory distress observation scale for
patients unable to self-report dyspnea. J Palliat Med. 2010;13(3): 285-290. doi:
10.1089/jpm.2009.0229
21.  Yao H, Sundar IK, Huang Y, Gerloff J, Sellix MT, Sime PJ, et al. Disruption of
SIRT1-mediated control of circadian molecular clock and inflammation in chronic
obstructive pulmonary disease. Am J Respir Cell Mol Biol. 2015;  53(6): 782-792. doi:
10.1165/rcmb.2014-0474OC
22.  Geraghty P, Hardigan A, Foronjy RF. Cigarette smoke activates the proto-oncogene
c-src to promote airway inflammation and lung tissue destruction. Am J Respir Cell
Mol Biol. 2014; 50(3): 559-570. doi: 10.1165/rcmb.2013-0258OC
23.  Alexander Crotty LE, Shin S, Hwang JH. Inflammatory diseases of the lung induced
by conventional cigarette smoke: a review. CHEST Journal. 2015; 148(5): 13071322.
24.  Heijink IH, Pouwels SD, Leijendekker C, de Bruin HG, Zijlstra GJ, van der Vaart H,
et al.(2015). Cigarette smoke-induced damage-associated molecular pattern release
from necrotic neutrophils triggers proinflammatory mediator release. Am J Respir
Cell Mol Biol, 2015; 52(5): 554-562. doi: 10.1165/rcmb.2013-0505OC
25.  Barouchos, N., Papazafiropoulou, A., Iacovidou, N., Vrachnis, N., Barouchos, N.,
Armeniakou E. Comparison of tumor markers and inflammatory biomarkers in
chronic obstructive pulmonary disease (COPD) exacerbations. Scand J Clin Lab
Invest, 2015; 75(2):126-132. doi: 10.3109/00365513.2014.992944
26.  Haw TJ, Starkey MR, Nair PM, Pavlidis S, Liu G, Nguyen DH et al. A pathogenic
role for tumor necrosis factor-related apoptosis-inducing ligand in chronic obstructive
pulmonary disease. Mucosal Immunol. 2016; 9: 859-872. doi:10.1038/mi.2015.1
27.  Zhou H, Hua W, Jin Y, Zhang C, Che L, Xia L. Tc17 cells are associated with
cigarette smoke-induced lung inflammation and emphysema. Respirology, 2015;
20(3): 426-433. doi: 10.1111/resp.12486
28.  Bafadhel M, Haldar K, Barker B, Patel H, Mistry V, Barer MR. Airway bacteria
measured by quantitative polymerase chain reaction and culture in patients with
stable COPD: relationship with neutrophilic airway inflammation, exacerbation
frequency, and lung function. Int J Chron Obstruct Pulmon Dis, 2015; 10: 10751083. http://hdl.handle.net/2381/36386
29.  Li, X., Wang, T., Yang, T., Shen, Y., An, J., Liu, L. Elevated plasma levels of
pigment epithelium-derived factor correlated with inflammation and lung function in
COPD patients. Int J Chron Obstruct Pulmon Dis.2015; 10: 587-594.
doi:10.2147/copd.s78546
30.  Ungurs MJ, Sinden NJ Stockley RA. Progranulin is a substrate for neutrophil-elastase
and proteinase-3 in the airway and its concentration correlates with mediators of
airway inflammation in COPD. Am J Physiol Lung Cell Mol Physiol, 2014; 306(1):
L80-87. doi: 10.1152/ajplung.00221.2013

  

31  

31.  Schuliga M. NF-kappaB Signaling in chronic inflammatory airway disease.
Biomolecules. 2015;5(3): 1266-1283. doi: 10.3390/biom5031266
32.  Sze MA, Utokaparch S, Elliott WM, Hogg JC, Hegele RG. (2015). Loss of GD1positive Lactobacillus correlates with inflammation in human lungs with COPD. BMJ
Open. 2015; 5(2): e006677. doi: 10.1136/bmjopen-2014-00667
33.  Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL. Chronic obstructive
pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med.
2010; 182(5): 598-604. doi: 10.1164/rccm.200912-1843CC
34.  Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the chronic care model in
the new millennium. Health Aff (Millwood), 2009; 28(1): 75-85. doi:
10.1377/hlthaff.28.1.75
35.  Mayo Foundation for Medical Education and Research. 2016.
http://www.mayoclinic.org/diseases-conditions/copd/basics/definition
36.  Tantucci C, Expiratory flow limitation definition, mechanisms, methods, and
significance. Pulm Med. 2013: 1-6.749860. doi: 10.1155/2013/7498
37.  American Lung Association. (2016). http://www.lung.org/lung-health-and-diseases.
COPD.
38.  Bailey, P. H. (2001). Death stories: acute exacerbations of chronic obstructive
pulmonary disease. Qual Health Res. 2001; 11(3): 322-338.
39.  Hareendran A, Palsgrove AC, Mocarski M, Schaefer ML, Setyawan J, Carson R. The
development of a patient-reported outcome measure for assessing nighttime
symptoms of chronic obstructive pulmonary disease. Health Qual Life Outcomes.
2013; 11(104): 345-355. doi: 10.1186/1477-7525-11-10
40.  Mullerova, H., Maselli, D. J., Locantore, N., Vestbo, J., Hurst, J. R., Wedzicha, J. A.,
. . . Anzueto, A. (2015). Hospitalized exacerbations of COPD: risk factors and
outcomes in the ECLIPSE cohort. Chest, 147(4): 999-1007. doi: 10.1378/chest.140655
41.  Deutschman CS, Ahrens T, Cairns CB, Sessler CN, Parsons PE. Multisociety task
force for critical care research: key issues and recommendations. Am J Respir Crit
Care Med, 2012; 185(1): 96-102. doi: 10.1164/rccm.201110-1848ST

  

32  

Table 1. Inflammation in COPD: Conceptual Components
Antecedents

Attributes

Abnormal inflammation in COPD
result of various causes: noxious
stimuli such as air pollution
(outdoor, indoor, and
occupational), cigarette smoke, and
a1 antitrypsin deficiency (an
inherited disorder).
Noxious stimuli or genetic disorder
that trigger inflammatory mediators
in lung tissue resulting in COPD.
Exacerbations of COPD from
bacterial, viral infections, or
airborne pollutants.

Consequences

Airway inflammation that is
chronic and contributes to the
progressive decline of lung
function.
Acute ECOPD episodes signals a
worsening of the disease
progression.
Cough with or without sputum,
dyspnea, and impaired exercise
tolerance.
Phenotypes of COPD: mixed
COPD-asthma, emphysemahyperinflation, and chronic
bronchitis.

Acute exacerbation of COPD: acute
impaired gas exchange (hypoxia
and/or hypercapnia), respiratory
failure, need for supplemental oxygen
delivery, ventilator assistance
(mechanical ventilation or bi-level
positive airway pressure (BiPAP).
Anxiety and depression contributes to
perceived impaired quality of life
Increase in morbidity and mortality.
Social and financial burden to the
healthcare system in the United States
and globally.

Table 2. Observation Instrument to Assess Dyspnea - Respiratory Failure20
  

  

  

  

Mild  Shortness  of  
Breath  

Moderate  Dyspnea  

Severe  Dyspnea  

Respiratory  Failure  

Respiratory  rate  22-‐
26/minute  

Respiratory  rate  28-‐
32/minute  

Fearful  Facial  
expression  

Slight  labored  
respirations  

Respiratory  rate  33  to  
>/min  

Respirations:  severe  
labored,  grunting  or  
apneic  periods  

Retractions  (chest)  

Labored  
respirations/Nasal  
flaring  

Cyanotic:  lips,  nail  
beds,  mucus  
membranes  

Diaphoretic  
Severity  Score  =  1  

Severity  Score  =  2  

Severity  Score  =  3  

Severity  Score  =  4  
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Table 1. Instruments to Determine Risk Factors for Hospital Admission among Patients
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Table 3: Validity and Reliability of Instruments for Risk Factors
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Abstract
Background: Discharge instructions for hospitalized patients with chronic obstructive
pulmonary disease (COPD) are essential to promote improved health outcomes, reduce
incidence of rehospitalization, and improve perception of quality of life (QOL).
Objectives: This study evaluated the feasibility of implementing the American Lung
Association’s modified COPD Action Plan and assessment of QOL among participants
hospitalized for an acute exacerbation of COPD (AECOPD) or COPD.
Methods: A feasibility study was conducted on a cohort of critically ill participants with
COPD hospitalized on a Progressive Care Unit. Nurses were trained to deliver the
modified COPD Action Plan, and the Principal Investigator administered the World
Health Organization Quality of Life-Brief (WHOQOL-BREF) questionnaire to assess
QOL before discharge and 30 days after discharge via phone call. RE-AIM (Reach,
Effectiveness-Adoption, Implementation and Maintenance) Framework was used to
evaluate outcomes.
Results: In hospital enrollment (n = 50 participants); 13 completed both the in-hospital
and 30-day follow-up assessments. There was in hospital dropout (n = 1), reported deaths
on 30 day follow-up (n =2) and those not reached by phone (n = 34). Participants’
answer to whether self-management skills were learned from the action plan (12; 92.3%
answered “Yes”). WHOQOL-BREF scores were compared using the Wilcoxon signedranks test; there were no statistically significant difference between in hospital and 30
day follow-up scores.
Conclusions: Administration of COPD instructions can increase patient satisfaction in
receiving self-management instructions from an action plan near time of discharge based
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on a small follow-up sample. There was no significant change in QOL scores obtained
from the follow-up group in this study. Keywords: COPD, action plans, education, selfmanagement, quality of life
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Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive inflammatory
lung disease that results in airflow limitation, which is treatable but presently not curable
(Celli et al., 2015). The physical, psychological and economic burden of living with
COPD negatively affects the QOL of patients and their caregivers. COPD is the third
leading cause of death in the United States, and management of the disease remains
suboptimal (National Institutes of Health, 2013). Tremendous financial responsibility
exists for both patients and the health care system, due to the high consumption of
resources (Jennings et al., 2014). The average US hospital readmission rate within 30
days post discharge for COPD is reported at 20.2%, and Centers of Medicare and
Medicaid (CMS) have established penalties in financial reimbursement to hospitals for
these readmissions, necessitating more effective chronic care management for these
patients (Centers of Medicare and Medicaid, 2014). Action plans are strategic
instructions used to help nurses educate patients on disease entities and symptoms with
information on appropriate actions to take. A goal of action plans, as in COPD, is to
teach self-management skills in order for patients to prevent delay in seeking care and
worsening outcomes of morbidity and mortality (Sanchez et al., 2016).
Based on the diverse needs and backgrounds of patients with COPD, it is essential
to deliver discharge instructions individually (Hanania, 2012; Sheppard et al., 2013). A
compounding factor, however, is that many individuals with COPD, are of lowsocioeconomic status (City Data, 2015; Gershon, Dolmage, Stephenson & Jackson,
2012). Low-socioeconomic status encompasses lack of education, economic resources,
and occupational risks (Gershon, Dolmage, Stephenson & Jackson, 2012). Thus, concise
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discharge instruments are needed to specifically provide COPD self-care instructions to
improve QOL (Kansagara et. al, 2011). Incorporating consideration of compounding
factors such as comorbidities, socioeconomic status, and anxiety mostly related to
breathless episodes, into discharge instructions is critical to gaining effectiveness and
satisfaction in the delivery of nurse-patient education to patients with COPD (Coventry,
Gemmell, & Todd, 2011; Polster, 2015).
The purpose of this study was to evaluate the feasibility of implementing the
American Lung Association (ALA) modified COPD Action Plan (page 1 of 2) as a
systematic discharge education of patients with COPD and to assess their QOL using the
WHOQOL-BREF (ALA, 2013; WHOQOL-BREF, 1997). This structured discharge plan
targeted patients with COPD receiving care in an acute care setting.
Gap in Evidence
Based on the literature, there is a growing body of evidence to support the
effectiveness of specific patient education and discharge instructions, such as the use of
action plans, delivered during outpatient visits or hospitalization (Almago & Castro,
2013; Mularski et al., 2012). For example, action plans for asthma have been studied for
their educational impact on respiratory symptoms and self-management outcomes. In a
meta-study, Jalota and Jain (2016) report that 400 asthma action plans have been
investigated as to their effectiveness in teaching self-management of symptoms compared
to data published from 69 studies on COPD action plans. These findings on asthma
action plans indicated effectiveness in prevention of more severe asthma exacerbations
but little information was available on QOL. In comparison, researchers concluded
COPD action plans are likely to be effective if they are patient-centered and COPD-
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specific, take into account comorbidities, and have a multidisciplinary approach (Jalota &
Jain, 2016).
Mixed Evidence: Benefits, Inpatient or Outpatient, Evaluation of QOL
Similarly, COPD action plans are beneficial to patients, but they too are limited in
outcomes on QOL, based on a review of action plans and the role of antibiotics in selfmanagement for patients with AECOPD (Jalota & Jain, 2016). Bischoff et al. (2011)
reported use of a COPD action plan given to 252 participants who also received either
hospital-based exercise or home-based exercise for patients in a one year prospective
cohort study. Reduced ECOPD recovery time (0.0001) was reported but the action plan
did not impact unplanned healthcare utilization (OR 0.94, 95% CI 0.49 to 1.83) (Bischoff
et al., 2011). There was no report of QOL evaluation as noted by Bischoff et al. (2011).
Sanchez-Nieto et al. (2016) conducted a multicenter, randomized study that taught selfmanagement skills to 85 outpatients, providing one group teaching session and then
subsequent individual teaching sessions. QOL was assessed using the COPD Assessment
Test (CAT), (p = 0.286). Findings reported by Sanchez-Nieto et al. (2016) included
incidence of hospitalization for ECOPD in comparing control group (CG) to intervention
group (IG) decreased, 52 versus 42.
Benefits of COPD education. Findings from a prospective study conducted over a one
year period, used a COPD self-management education plan, by Labrecque et al. (2011).
The same researchers reported 57 outpatients with stable COPD showed a decrease in
emergency department (ED) visits compared to 45 patients who did not receive
instruction (p = 0.002) (Labrecque et al., 2011). Hospitalizations were reduced in the
education group, but this finding was not statistically significant (p = 0.17), and
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improvements in health-related quality of life (HRQOL) (p < 0.001) were observed.
Similarly, Scott and colleagues (2011) compared knowledge of COPD and information
needs of 38 inpatients and 43 outpatients with COPD diagnosed 9 +/- 7 years prior and
measured these outcomes using two questionnaires. Reported results showed a positive
correlation between prior COPD learning and high school education (p < 0.05), and a
positive correlation was found from prior COPD instructions and lower Lung Information
Needs Questionnaire (LINQ) score (p < 0.01). The need for further education on diet and
self-management was identified. No measurement of QOL was reported by Scott et al.
(2011).
In cross-sectional descriptive study, Choi, Chung, and Han (2014) taught 126
participants with COPD during clinic visits how to care for their respiratory condition
and prevent ECOPD. Results suggested improved adherence to an action plan and
reduced unplanned hospitalizations (p = 0.001). QOL measured with St. George’s
Respiratory Questionnaire (SGRQ) results mean (standard deviation) 37.79 +/- 18.99.
Trappenburg et al. (2011) conducted a multicenter randomized controlled trial to test the
effectiveness of administering personalized COPD action plans to reduce exacerbation
recovery time in 233 patients. Patients were recruited during scheduled outpatient visits
(n =111) in the individualized action plan and (n = 122) usual care. SGRQ was used to
report QOL in this study (p = 0.42). Every three days participants completed the Clinical
COPD Questionnaire (CCQ) to measure health status, starting as out-patients and then at
home or if they were hospitalized. Results of the CCQ scores indicated improvements in
health status related to a decrease in exacerbations (p ≤ 0.01). Ko et al. (2016) carried out
a randomized controlled trial to assess the impact of a comprehensive intervention for
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patients recently discharged from the hospital for AECOPD. Compared to the control
group that received standard instructions, the group receiving the intervention
experienced a reduction in hospitalization for AECOPD (p = 0.047) and decreased length
of stay (LOS) (p ≤ 0.001). The investigators did not report what particular aspect of the
intervention was most effective.
Sanchez-Nieto et al. (2016) conducted a randomized controlled trial that enrolled 89
patients, who months prior, had either been hospitalized for ECOPD or treated in the
emergency department (ED). These researchers found incidence of ECOPD, in the
intervention group, decreased from 52 to 42 (Sanchez-Nieto et al., 2016).
Fan et al. (2012) conducted a randomized controlled trial of patients with COPD
who had been hospitalized within 12 months prior to enrollment for COPD. The
comprehensive program educated 209 participants in the intervention group to selfinitiate antibiotics and prednisone for ECOPD and 217 in the usual care group. When it
was identified that the mortality rate was higher in the intervention group 28 compared to
10 receiving usual care the study was stopped (Fan et al., 2012). This outcome was not
defined but surmised that participants in the intervention group may have been over
confident in self-treatment and delayed seeking medical care.
Best Practice Discharge Models: Reducing Hospital Readmissions and Improving
Outcomes
The COPD Foundation held a multi-stakeholder National COPD Readmissions
meeting in 2013 to establish evidence-based practices to reduce hospital readmissions.
Krishnan et al. (2015) reported that no specific evidence-based COPD educational
instruments were produced from this meeting. Evidence-based programs were identified
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to educate on disease symptoms and actions to take, as well as scheduling post-hospital
office appointments included: Society of Hospital Medicine’s (SHM), Project ReEngineering Discharge (RED), Care Transitions Intervention, Project Better Outcomes
through Optimizing Safe Transitions (BOOST), and the Transition Care Model.
Providing an individualized approach to educating self-management for patients with
COPD was emphasized along with identification of comorbidities such as congestive
heart failure (CHF) and diabetes (DM) which pose challenges to self-management of
COPD (Krisman et al., 2015).
Furthermore, findings were reported from several studies that multidisciplinary
educational action plans which included evaluation of QOL, physical exercise, and
follow up phones calls to patients after discharge, decreased hospitalizations (Krishnan et
al., 2015). Evidence of these comprehensive discharge programs revealed bundle
interventions (education, exercise, and follow up phone calls after discharge) such as
BOOST for COPD patients, reporting a 2% 30-day hospital readmission reduction
(Krisman et al., 2015). Incidentally, BOOST does not include home visits. Results
reported improved outcomes, fewer hospitalizations, and increased QOL (Hansen et al.,
2013).
Mularski et al. (2012) examined comparative effectiveness research for patients
with COPD reporting gaps in evidence on effective education strategies such as proper
instruction on use of inhalers, setting follow-up appointments after discharge and
evaluating QOL. They called for collaboration among researchers, clinicians, payers, and
policymakers in broadening methodologies such as repeating performed effectiveness
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designs that examine longitudinally over time positive and negative outcomes, as well as
expense (Mularski et al., 2012).
COPD action plans are promising to patients with COPD, helping them acquire
knowledge, increase their confidence in managing their lung disease, and deciding when
to contact health care providers. However, few studies have confirmed whether specific
action plans for COPD delivered as discharge instructions are an effective approach to
reduce hospital admissions and influence quality of life (Bischoff et al., 2011; Effing et
al., 2012; Jennings et al., 2014). Future studies are needed that detail implementation and
content of instructions (pharmacological and nonpharmalogical), and how discharge
instructions could be individualized based on assessment of prior participant knowledge
of self-management and evaluation of QOL (Effing et al., 2012; Mularski, 2012; Polster,
2015).
As important as it is to assess outcomes on health, it is equally as important to
assess the feasibility of instructional models and their uptake during discharge. Another
consideration, is a need for uniformity in delivering COPD discharge instructions (either
written, audiovisual, or electronic tablet-based) to improve self-management among
patients with COPD (Choi et al., 2014; Mularski et al., 2012). The present study sought
to provide an initial understanding of the feasibility of delivering one type of action plan
to critically ill patients with COPD and whether there are perceived benefits on QOL.
Specifically, the aims of this study were to 1) evaluate the feasibility of implementing the
COPD modified Action Plan as part of the discharge instructions for patients with COPD
or an exacerbation of COPD (ECOPD), hospitalized on a PCU;
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2) compare QOL measured using the WHOQOL-BREF valid instrument and patient
response scores before discharge, and at 30 days post discharge; and 3) explore
discharged patients perceptions related to the action plan, regarding whether or how this
instrument assisted them to gain knowledge of self-management with COPD (e.g.,
number of hospitalizations, emergency department (ED) visits, etc.). Outcomes of this
feasibility study were measured with the RE-AIM Framework.
Theoretical Framework
The Social Ecological Model (SEM) was used to guide the development of the
structured discharge educational protocol and QOL evaluation for the present study
because SEM recognizes the interconnectedness in layers of influence for patients with
COPD (Centers for Disease Control and Prevention, 2015). The framework consists of
multiple levels of influence which include: the individual, his/her knowledge, motivation
and skills; interpersonal relationships that consists of family, friends and social network;
organizations, involving environmental factors (home or work) such as air pollutants
indoors and outdoors. Additionally, community resources are composed of connections
and support between organizations in the community and home. Public policies embody
the laws to support and protect individuals and communities (Glasgow, Vogt & Boles,
1999). The SEM provided a schematic design as to the interrelationships of factors to be
considered when this discharge intervention was developed to teach hospitalized patients
with COPD self-management skills and evaluate their perceptions of QOL.
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Research Question
What is the outcome of using the ALA COPD Action Plan in terms of self-rated
knowledge and assessment of QOL in a cohort of patients discharged after hospitalization
for an AECOPD or COPD?
Methods
Study Design
This prospective feasibility study used the ALA COPD modified Action Plan for
discharge instructions to evaluate the outcome on patients hospitalized for an AECOPD
J44.1 International Classification of Diseases (ICD) or for another illness, or had COPD
J44.9 ICD as a secondary diagnosis. In addition, QOL was assessed using the
WHOQOL-BREF questionnaire before hospital discharge and 30 days via phone call,
after hospital discharge. The study was conducted over six months (May, 2016 to
October, 2016) in a 24-bed PCU at a hospital in Kansas City, Missouri. Prior to this
study there was no formalized COPD action plan in place for nurses to review and
provide to patients with COPD on discharge from the hospital. The study received
expedited approval from the Medical University of South Carolina’s institutional review
board (IRB) and the hospital’s research operating committee. Informed consent was
obtained from all participants.
Setting, Sample and Recruitment
Participants were recruited from a 24-bed PCU located in an urban area of
western Missouri that serves a population 473,000 of racially diverse individuals (City
Data, 2013). Among this population, most patients live within a 150 mile radius of the
hospital in the urban and surrounding area (Research Medical Center, 2016). City data
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(2015) reported that 14.3% of Kansas City residents live with income below the poverty
level, as compared to 11.7% for the whole state. It was anticipated that retention of the
sample would be a challenge in the 30 day follow-up based on follow-up in previous
studies at the hospital where the study was conducted (Feeback, 2015). The original
sample size of 25 was doubled to 50 to obtain adequate data to evaluate the feasibility of
this study (Billingham, Whitehead & Julious, 2013).
A majority of this population with COPD have multiple comorbid conditions:
renal disease, diabetes, congestive heart failure, and depressive symptoms (Maters,
2014). Inclusion criteria included adults: 18 years-of-age and older, discharged to selfcare, home (independently or with family/significant other), have a primary or secondary
diagnosis of exacerbation of AECOPD (J44.1 ICD) or COPD (J44.9) International
Classification of Disease (ICD-10, 2011), score 15 on the Glasgow Coma Scale,
understand and speak English, have access to a working phone, and have an address to
receive mail. Exclusion criteria consisted of patients with a tracheostomy, not able to talk
or communicate using BiPAP (noninvasive bi-level positive airway pressure ventilation)
during the day or on mechanical ventilation. (Table 1. Provides the inclusion and
exclusion criteria for enrollment of participants). The Principal Investigator (PI) screened
potentially eligible patients with COPD from a daily census sheet, invited those who met
the inclusion criteria to participate, and obtained informed consent from those who
agreed. Demographic characteristics measured: age in years, gender, race, smoking
status, home oxygen use, body mass index (BMI) in kg/m2, marital status, home support,
education level, employment status, primary and secondary diagnosis ICD-10 codes were
collected from participants and/or their medical record.
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Measures
RE-AIM. To measure feasibility of this discharge instruction, the RE-AIM
framework was used (Glasgow, Vogt & Boles, 1999). Assessment of feasibility was
evaluated over various time points, such as after delivery of the action plan via the 30 day
follow-up phone call post discharge. Reach included recruitment and retention of the
sample population of participants with COPD hospitalized on a Progressive Care Unit
(PCU). Effectiveness was measured by assessing participants’ perceived benefits of the
COPD Action Plan, based on 30 day follow up feedback (survey and qualitative results).
A trained PCU nurse completed a questionnaire on how beneficial the discharge
intervention was perceived for participants with COPD and answered questions to
evaluate acceptance and feasibility of the action plan. Adoption was evaluated by PCU
nursing staff (rated responses) and participants’ perception of willingness to adopt the
discharge clinical procedure (rated responses and 30 day outcomes of health care
utilization and QOL outcomes). Implementation of the clinical procedure was appraised
by consistency in delivery (fidelity) of the COPD discharge procedure, given direct
observation, feedback from participants, and the nurse’s recommendations.
Maintenance will be determined following completion of this study’s results from the
trained PCU nurse and participants’ evaluations of the COPD Action Plan as an approved
institutional discharge procedure for patients with COPD (survey and qualitative results).
Quality of life. WHOQOL-BREF questionnaire includes 26 items that were read
and completed by the PI with the participant (Appendix II). The questionnaire assesses
QOL in four domains: physical, psychological, social relationships, and environment
(World Health Organization, 2014). WHOQOL-BREF questionnaire was selected for its
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documented sound psychometric properties and diverse application with adults sick and
well, and tested in 23 countries from the general population consisting of hospital,
rehabilitation, and outpatient settings (Skevington, Lotfy, & O'Connell, 2004).
Validation of the psychometric properties of this assessment instrument has been verified
in a cross-cultural adult survey (n = 11,830). Cronbach’s a was acceptable (p> 0.7) for
internal consistency reliability. The analysis was based on Multi-Trait/Multi-Item
Analysis Program (MAP). Construct validity based on Pearson correlations (one-tailed
test) between domains for the total sample was strong, positive, and highly significant (p
< 0.0001) (Skevington, Lotfy & O’Connell, 2004, p. 305).
Hawthorne, Hermann & Murphy (2006) reported guidelines for interpretation of
WHOQOL-BREF domain scores from two studies of adults in the community
categorized by gender, years of age, and health status. General norms for the WHOQOLBREF were: 73.5 (SD, 18.1) physical domain, 70.6 (SD, 14.0) psychological wellbeing,
71.5 (SD, 18.2) social relationships, and 75.1 (SD, 13.0) environment. Differences in
WHOQOL-BREF domain scores were significant when reported by health status and
decreased by 50% compared to those in excellent health (Hawthorne, Hermann &
Murphy, 2006).
Each participant was sent a postcard 14 days following discharge to remind them
of the 30 day follow-up phone call. (Figure 1). Participants were asked questions by the
PI via 30 day follow up phone call to determine feasibility of the discharge protocol and
satisfaction.
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COPD Discharge Education: COPD Action Plan and Monthly Calendar
The modified COPD Action Plan provides three classifications for patients to
daily self-identify changes in respiratory symptoms and takes action based on changes in
their respiratory condition (American Lung Association, 2013) (Table 2). Color zones
included: 1) Green Zone, patient is doing well/action take daily medications, 2) Yellow
Zone, patient is having a bad day/action: use immediate relief inhaler, call health care
provider immediately if symptoms worsen, 3) Red Zone, need for urgent medical
care/action: call #911 immediately and use immediate relief inhaler until help comes.
A monthly calendar was given to each participant to record daily with a check
next to the symbol representing the following: respiratory condition and well-being
described per ALA color zones, hospitalizations, ED visits, phone calls to health care
provider, etc. (Table 3). The calendar was to be returned after the 30 day follow up call
to the participant, in a hospital addressed stamped envelope provided by the PI.
Procedures for COPD Discharge Education
Three PCU nurses who volunteered to deliver the COPD discharge instructions
were trained individually. Nurses were informed about the purpose of the study and
entire study flow. The PI provided a standardized script for use with each participant in
this study to the nurse volunteers, and demonstrated the process of administering the
discharge action plan. The nurses were notified when patients enrolled and consented in
the study, and then requested to deliver the discharge education close to the time the
participant was to be discharged or on the day of discharge. The modified COPD Action
Plan was read to participants the day of or before discharge by the PI or trained nurse.
The participant was asked to “teach-back” in their own words, to describe what each zone
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represented in symptoms and the action to take. This clinical procedure took place in the
privacy of the participant’s hospital room.
Participants were provided with a monthly calendar to document daily symptoms,
and were instructed how to complete it. The PI administered the WHOQOL-BREF
questions after the modified COPD Action Plan instructions had been reviewed with each
participant. A copy of the action plan was then given to the participant to take home and
place in a prominent place as a guide to daily self-assessment.
As a component of the feasibility evaluation the trained PCU nurse who delivered
the action plan completed an evaluation form on adoption and implementation of this
discharge procedure. The evaluation was done two days after they conducted the
discharge education. (Table 4)
Delivery of COPD Action Plan
The Principal Investigator (PI) obtained lists of potentially eligible patients with
COPD from a unit census sheet. Patients meeting inclusion criteria were invited to enroll
in the study. Those who agreed to participate, signed the informed consent.
The PI read the WHOQOL-BREF questionnaire to the participants and recorded
their responses. Next the PI read the information to be filled in daily on the monthly
calendar by the participant. Then the participant’s address was recorded on a postcard to
be sent to him or her 14 days after discharge as a reminder of the 30 day follow up via
phone call. Participants received $5.00 gift card following completion of the instructions
and responding to WHOQOL-BREF questionnaire. Data were entered into a Research
Electronic Data Capture (REDCap) database, a secure web-based data management
system used for data capture from research studies (REDCap, 2015). The PI followed up
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with each participant by telephone, 30 days after discharge to collect data from the
monthly calendar, namely the number of office visits (scheduled and unscheduled),
emergency department visits, and hospitalizations. The WHOQOL-BREF questionnaire
was re-administered to participants and responses recorded by the PI. Participants’
scores of satisfaction were obtained related to their perceived satisfaction with the
delivery of action plan instructions and to evaluate their perceived gain in knowledge
regarding self-management skills to care for their COPD. After questions were
answered, a $5.00 gift card and stamped hospital addressed envelope was sent to the
participant to return the completed calendar.
Data Analyses
Quantitative data
All data were collected by the researcher and directly entered into the Research
Electronic Data Capture (REDCap) study database. Statistical analyses were then
performed using the Statistical Package for the Social Sciences (SPSS) 23.0 (IBM SPSS,
Armonk, N.Y.). Descriptive statistics were calculated for each variable. For continuous
variables, means, standard deviations (SD), medians, and minimum and maximum values
were calculated. For categorical variables, counts and percentages were calculated.
The WHOQOL-BREF scoring methodology was guided by a published handbook
(WHOQOL-BREF, 1996). Missing data were handled appropriately, < 20% of raw scores
missing in a domain resulted in no domain score. Domain scores were calculated from
item raw scores for each characteristic and each domain in accordance with the scoring
methodology. The calculation to transform each domain score was done with an algebraic
equation. Each item in the domain had a response score from 1 to 5, on a Likert scale.
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The actual raw score was subtracted by the lowest possible raw score of that participant
and then divided by the possible raw score range, next that sum was multiplied by 100.
Scores were transformed linearly 0 to 100. The transformation score with calculated in
REDCap before exporting into SPSS.
WHOQOL-BREF in hospital scores were compared to the 30-day follow-up
assessment domain scores by using the Wilcoxon signed-ranks test. Wilcoxon signedranks test was used to compare the ranks from four QOL domains of participants who
completed the WHOQOL-BREF in hospital after the modified COPD Action Plan
education session and to 30 day follow up via phone call after discharge. Differences
were considered statistically significant if the test statistic had a probability level of 0.05
or lower. In addition, a 95% confidence interval was calculated for all of the mean
difference scores. The two sample t-test was used to compare the sample that completed
the QOL questionnaire domains (physical, psychological, social relations, and
environment) in hospital and 30 day follow-up via phone call.
Qualitative data
This study utilized qualitative description to analyze the verbal data obtained from
participants during the 30-day call back, as open ended comments (Sandelowski, 2000).
The question to obtain verbal text, was the first among the survey and QOL questions
asked. The PI and a qualitative mentor read and reviewed all of the comments. Having
two researchers review the open-ended comments increases the trustworthiness and
confirmability (Krefting, 1991). The expertise of the PI being a bedside nurse on the
PCU for greater than ten years (prolonged engagement) helped to establish
trustworthiness among the participants (Krefting, 1991). The external audit of the data
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(participant responses) appraised by a senior qualitative mentor who verified
confirmability of the themes that emerged. All data for verbal responses (n =10) was
transcribed in writing by the PI on a hard copy of the WHOQOL-BREF during the
follow-up phone call, which was then kept in each participants’ file to provide an audit
trail. The construct was measured by face validity, a subjective form of validity,
pertaining to the question and responses by participants. The construct of interest
measured satisfaction and benefit of participants receiving self-management instructions
from the modified COPD Action Plan. There were no test-retest measurements to
provide evidence for reliability of this question.
Results
Demographics and Participant Characteristics
A total of 68 patients were approached, 50 agree to participate, 50 were enrolled
and 13 completed the 30 day follow up phone call. (Diagram I Illustrated the sample
population by Consolidated Standards of Reporting Trials (CONSORT). Demographic
characteristics (Table 5) of the sample were: age (mean, 64.5 year; SD, 9.5 years), range
was 49 years to 84 years, and gender: 26 (52%) females and 24 (48%) males. Of race
there were, 18 (36%) were African American/Black and 32 (64%) White. Among
participants, 19 (39.6%) answered, ‘yes’ to smoking status and 29 (60.4%) answered,
‘no’. Those who used home oxygen, reported, ‘yes’ 19 (39.6%) and ‘no’ to home oxygen
use 29 (60.4%). Body mass index (BMI) in kg/m2 recorded on participants, minimum
13.9 and maximum 70.0, (mean, 24.4; SD, 11.4). Marital status was self-reported by
participants as: 28 (56%) single, married 17 (34%), and divorced 5 (10%). Having home
support, participants who lived with someone assisting them with activities of daily
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living, 14 (29.2) ‘yes’ and 34 (70.8%) ‘no’. Education level was reported as followed:
some high school 34 (69.4%), some college 10 (20.4%), completed college 4 (8.2%), and
graduate school 1 (2.0%). Employment status of those not working 41 (83.7%) and those
working 8 (16.3%). Documented primary and secondary diagnosis with International
Classification of Diseases (ICD-10) codes were collected from participants’ medical
record. Primary diagnoses included: acute respiratory failure 10 (20%), AECOPD 4 (8%),
Healthcare-Associated Pneumonia 4 (8%), acute and chronic respiratory failure 3 (6%),
acute or chronic respiratory failure 3 (6%), and ECOPD 3 (6%). Secondary diagnoses
were documented as followed: COPD 19 (38%), ECOPD 13 (26%), AECOPD 7 (14%),
and hypoxia 2 (4%).
There were a total of 37 dropouts. One participant dropped out while in the
hospital, who did not complete the WHOQOL-BREF questionnaire after being enrolled,
while 34 others did not complete the 30-day follow-up assessment, and 2 deaths were
reported during the 30-day follow-up via phone assessment.
Feasibility Assessment. The RE-AIM framework was used to evaluate five dimensions,
beginning with reach, and defined as recruitment and retention. (Table 6). The target
sample of 50 participants were recruited, however only 13 were retained. Of the patients
that dropped out or could not be contacted at the 30 days visit; 1 dropped out in the
hospital, 2 died and 34 were not able to be reached by phone call on follow-up, or refused
to complete the 30 day follow-up survey and WHOQOL-BREF reassessment due to not
feeling well or being busy. Effectiveness, defined as outcomes and perception of benefit,
was assessed with the following question, “Do you think the discharge action plan taught
you to better take care of your respiratory symptoms and when to seek help?” Participant
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responses were yes 12 (92.3%) and no 1 (7.7%) participant response was “It didn’t cure
me.” Satisfaction with the modified COPD Action Plan and delivery by participants was
rated, high 4 (30.8%), moderate 9 (69.2%), and low 0 (0%). Based on qualitative
comments from participants on 30 day follow-up, three themes emerged from the
comments. 1) Perceptions about Delivery of the modified COPD Action Plan reflected
an appreciation of knowledge gained, two responses, “Person to person is always good”
and “No one (before) took the time to go over this with me. I appreciate it.” 2)
Participants discussed feeling better related to Improved Self-Management Skills with a
participant stating, “Doing exceptionally well. Eating healthy and stopped smoking,” and
another “Great.” 3) Consequences of Decline related to COPD, “When real hot out, slow
deep breaths still don’t help.”
One trained PCU nurse completed a follow-up survey. The response from the
PCU nurse on “rated acceptability and ease of delivery of action plan,” was moderate
because the nurse said based on each patient’s existing knowledge of COPD selfmanagement, educational background and general well-being, more explanation of the
action plan instructions may be needed for some patients. Reply by the PCU nurse to,
“Do you see this action plan as a benefit for future patients with COPD?” Response was
‘Yes’. (Table 7).
Adoption was evaluated by rated responses and 30 day outcomes of health care
utilization and QOL outcomes. Wilcoxon signed-ranks test of median QOL scores
indicated no statistical significance among domains (score of differences between means
in hospital and 30 day follow-up). The following are the domain scores (mean in
hospital, mean 30 day follow-up and p value): physical (49.3; 55.8; p = .78);
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psychological (64.8; 70.8; p = .40); social relations (60.0; 55.8; p = .79), and environment
(70.2; 72.4; p = .59) Participants rating of satisfaction with action plan and delivery was
high, 4 (30.8%), moderate, 9 (69.2%), and low, 0(0%). Health care utilization post
hospital, 30 day follow-up: number of ED visits: 12 (99%) no ED visits and 1 (1%) ED
visits for an insulin reaction. The number of reported hospitalizations following
discharge, 12 (99%) no hospitalizations and 1(1%) hospitalized 2 days for COPD.
Number of times participants called #911 since discharge was, 0 (100%), number of
office visits reported were, 5 (40%) no visits, 7 (55%) had scheduled visits, and 1 (5%)
had an office visit not related to COPD. (Table 8). Implementation was evaluated on
consistency in delivery (fidelity) of the COPD discharge procedure, feedback from
participants, and the nurse’s recommendations.
Survey outcome of PCU trained nurse responses, post administration of the
modified COPD Action Plan rating for length of time to deliver the action plan” answer
by the PCU nurse was ‘15 minutes’. The PI observed the PCU nurse’s consistency
(fidelity) according to scripted dialog in delivery of the COPD discharge procedure.
Only one trained PCU nurse was observed due to limitation in availability of nurses when
participants were enrolled in the study and ready to receive the discharge instructions.
Maintenance was the final dimension to determine feasibility of the study. The
discharge intervention could be considered a potentially strategic intervention using the
ALA modified COPD Action Plan but use of the WHOQOL-BREF demonstrated no
significant evidence in change of scores from in hospital to 30 day follows up via phone
call.
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Quantitative findings (QOL). Of the 30 day follow-up calendars, 2 were
returned completed with the following results: participant (1) green was marked for good
day = 88% (28 days out of 32 total days recorded), yellow marked for some problems
breathing = 0.5% (2 days out of 32) and 3% (2 days out of 32, nothing was recorded).
Participant (2) green marked = 64% (18 day out of 28 total days recorded), yellow
marked = 36% (10 days out of 28). SPSS was used to calculate results on the
transformed domains in hospital (n = 49) and on 30 day follow-up (n = 13). Scores
below 70 would be considered a perceived low QOL, as indicated by the interpretation of
WHOQOL-BREF scores from Hawthorne, Herrman & Murphy (2006). The participants
who completed the study on 30 day follow up (n = 13) rated social and physical domains
as the lowest rated of the four domains, each with a mean 55.8, which is considered a low
perceived QOL.
The Wilcoxon signed-ranks test indicated that there was no significant difference
in QOL between in hospital and 30 day follow up of 13 participants. Thus, the null
hypothesis is retained, as there is no difference between the ranks of in hospital QOL and
30 day discharge follow-up QOL scores. Since the sample (n = 13) of participants
retained who completed the study was small, the standard deviation and the 95%
confidence interval (CI) of the difference in mean scores (in hospital and 30 day followup) was calculated to determine amount of difference. Wilcoxon signed-ranks test was
used to calculate the z scores. CI and z score results of QOL domains were: physical (CI
-7.3, 10.0), z = -.28; psychological (CI -5.4, 15.0), z = -.85, social; (CI -11.9, 9.4), z = .27; environment (CI -10.6, 5.8), z = -.54.
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The WHOQOL-BREF mean score differences between in hospital scores and 30
day follow via phone call scores were, physical (+1.4) and psychological (+4.8) indicated
an increase in both domain scores though not statistically significant. Increase in the
mean score could indicate participants being more active at home, experiencing some
physical improvement. The psychological domain had the greatest increase in mean
score (+4.8) of the 4 domains but was not statistically significant. This possibly reflects
participants feeling better mentally being at home in familiar surrounds and for some
being near family or loved ones. Social mean domain difference in score of (-1.3) might
reflect participants with less or no social support at home, as 17 (34%) participants
reported being single. Environment score (-2.4) may indicate poor air quality if exposed
to smokers or poor housing conditions. Differences in social and environment mean
domain scores were not statistically significant.
Qualitative findings (30 Day Follow Up)
Participants were called at their requested time and day in accordance with the PI
availability, which was scheduled with the PI during the in hospital portion of the study.
Comments were evaluated from 10 out of the 13 participants who offered responses to
the first question asked during the 30 day phone follow up. Overall, most participants
were weak and become short of air (dyspneic) during phone call, and would simply
answer the rated questions for evaluation of the action plan and QOL questions. The
comments were summarized into themes relevant to the question concerning, satisfaction
with receiving self-management instructions from the COPD Action Plan. From the
analysis of the data, words used by participants, three prevailing themes emerged as
previously described. Since there was a small sample of participants who completed the
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30 day follow-up call, and 10 out of 13 providing responses to one question, resulted in a
scant amount of text to analyze. Minimal responses from participants were due to them
being weak and dyspneic from their COPD, and for many, having comorbidities.
Discussion
Overall findings from the study indicated the targeted PCU population was able to
be recruited; administration of the modified COPD Action Plan was achievable by a
trained PCU nurse and the PI. Obtaining participants QOL scores could be obtained when
the PI read and recorded them at the bedside. The study had limited feasibility due to lack
of retention in the 30 day follow-up. There were no significant differences from the QOL
questionnaire mean scores before hospital discharge compared to 30 day follow-up per
phone call. Even though a small sample of participants completed the study (n =13), they
reported positive satisfaction ratings with the instructions from the action plan. Only one
reported being hospitalized for a health issue not related to COPD. In addition, from the
qualitative data in the follow-up, three themes surfaced as described in qualitative
findings.
Although much emphasis has been made about the correlation of QOL to outcome
measures of patients with COPD, there is inconsistency and lack of significant findings
from self-management instructions on QOL. Ko et al. (2016) reported, in their
comprehensive intervention for patients recently discharged for an AECOPD, the
intervention group showed a decrease in hospital readmissions and at 12 months a mean
improvement of -6.9 points in total St. George’s Respiratory Questionnaire (SGRQ)
measuring health-related QOL. In comparison, researchers who used a COPD Action
Plan found adherence to instructions was negatively associated with unplanned
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hospitalizations but findings indicated no significant relationship with QOL scores (Choi,
Chung & Han, 2014). Trappenburg et al. (2011) found that use of an action plan,
teaching increased knowledge among patients to identify symptoms of ECOPD, did not
decrease healthcare utilization or improve health-related QOL. Bischoff et al. (2011)
and researchers studied the impact of using a COPD action plan for recognition of
ECOPD symptoms, along with standing orders for prednisone and antibiotics, did not
include an evaluation of QOL. The lack of statistical improvement in QOL scores from
the findings of this feasibility study and other published studies that examined QOL, begs
the question, are most patients with COPD so impaired by their health (COPD and
comorbidities) and/or their socioeconomic status that they do not perceive QOL
improvement?
Gaining insight into the perceptions of the participants was important to examine
in relationship to the delivery of the COPD Action Plan, because the findings are relevant
to the feasibility of the study. Participants’ verbal acknowledgment in gaining real life
self-management skills that could help improve their QOL, may also decrease their risk
of hospitalization or rehospitalization for an AECOPD. Maintaining privacy and nurse to
participant interaction of the discharge protocol may have helped promote learning and
satisfaction in the survey outcome measures, but no improvement in the QOL domain
scores. Establishing trust among participants in their interaction with the PI, was a goal,
in order that they would feel comfortable to ask questions and share their comments.
Futhermore, the literature reports inconsistency on the content and benefit of
education for patients with COPD, being disease specific or general as found in discharge
models such as Re-Engineered Discharge (RED) toolkit. The RED discharge model has
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minimal instructions on actions for patients to take related to disease symptoms for
COPD (RED, 2016). Bischoff et al. (2011) reports limited positive outcomes using a
written COPD action plan, from which there was no decrease in healthcare utilization
among participants. Fan and researchers (2012) reported their study being stopped
because of a high mortality rate in the intervention group than usual care group, of those
who received self-management instructions (pharmacological and nonpharmalogical).
Such outcomes could indicate giving participants’ options to initiate pharmacological
interventions for self-management of developing ECOPD symptoms can be potentially
detrimental.
While previous research suggests a need for ongoing communication with
participants to support the action plan instructions, no time frames have been established
(Bischoff et al., 2011). This study noted that patients reported satisfaction related to
implementation of the ALA modified COPD Action Plan, as noted in comments and
ratings from patients. The trained PCU nurse in our study found the action plan to be a
reasonable protocol to administer to patients with COPD before or on the day of
discharge. Therefore, we conclude that the COPD discharge protocol using an action plan
is partially feasible in the acute care setting, but follow-up via phone call lacked
feasibility, as shown by the insufficient retention of participants. Dropouts in follow-up
were an anticipated obstacle from previous studies at this hospital that did phone followup. The high dropout number rate could be a consequence of this population being high
risk for multiple reasons: the severity of their COPD disease, comorbidities,
socioeconomic factors, and unstable home environment. When participants were called
for the 30 day follow-up, some refused to complete the survey and questionnaire stated
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the following reasons; “I’m moving right now,” “I don’t feel well,” “Can I answer the
questions for my husband (participant)?” and another participant was too drowsy. Also,
participants did not all want to answer the question rating satisfaction with their sexual
activity and for some it created a distraction (they wanted to go into detail).
Key components of this feasibility study merit future consideration and
evaluation: 1) determining the optimal timing for delivering COPD instruction, at least
one day before discharge, 2) determining the effectiveness of a 15 to 20 minute patient
education session to provide , concise content of ALA modified COPD Action Plan
instructions, 3) evaluation of a more concise QOL instrument and 4) reconsideration of
large incentives ($10 gift card) or meeting participants at office or clinic visits for followup communication and evaluation from participants.
The PI sitting down next to each participant to deliver the instructions, nurse to
participant, provided an opportunity for participants to ask questions, which in some
cases enabled valuable teaching. In several cases the participants reported having
difficulty getting appointments when they developed abnormal, non-emergent respiratory
symptoms (increased dyspnea or colored sputum production). In these instances,
participants were instructed on options to seek medical attention such as urgent care
centers or the emergency department. The instruction session was preemptive to help
most participants identify the connection between waiting too long to receive medical
attention and hospitalization. Likewise, participants were able to see the resulting
detrimental effects of smoking or other airborne (indoor or occupational) inhalation
irritants that may have led to their hospitalization, in some cases an AECOPD or
respiratory failure. Depending on participants’ educational and reading level, reading
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comprehension was not assessed, reading to the participants insured the instructions of
the action plan was conveyed, and a teach-back assured understanding. Participants
allowed the PI to read the QOL questionnaire while holding it in front of them and
recording their answers, since most were weak and dyspneic. Implementing an action
plan on the day of discharge or a day before was best completed the day before discharge,
when participants were not waiting for a ride and rushing to leave the hospital to go
home. Potential moderators affecting the outcomes of this study included: literacy of
participants, time spent sitting at the bedside to deliver the action plan and obtaining
responses from the QOL questionnaire, gift card, nurse to participant interaction, privacy
of the participants’ room, severity of COPD, and time frame presenting information in
most cases the day before discharge.
WHOQOL-BREF is a 26-item comprehensive instrument to evaluate QOL. The
WHOQOL-BREF was selected for its documented validity and reliability to evaluate
QOL and is among one of the more brief questionnaires available. Comparing the
WHOQOL-BREF to St. George’s Respiratory Questionnaire (SGRQ) that is a 50-item
questionnaire and a shorter version of SGRQ, which is a 40-item questionnaire; the
WHOQOL-BREF has fewer questions. Due to the fact that this patient population suffers
with dyspnea resulting in limited endurance and ability to concentrate in order to take in
information or answer questions, a shorter questionnaire of 5 to 6 questions would be
more realistic to administer. Studies that examined action plans to educate on selfmaintenance of COPD primarily used the SGRQ to evaluate QOL (Ko et al., 2016;
Trappenburg et al., 2011) Development of such an instrument will require testing for
validity and reliability. A wide spread of BMI results possibly reflected on the low end
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(13.9 Kg/m2), a lack of nutritional intake and at the high end (70.0 Kg/m2), the probable
consequence of poor food choices or availability, along with inactivity due to poor
endurance from breathlessness caused by COPD. The primary diagnosis of acute
respiratory failure could reflect participants delay in seeking medical care for changes in
their respiratory condition and in some cases is an indication of the severity of their
condition and/or impact of comorbidities.
The ALA modified Action Plan delivered for each participant was part of their
overall discharge instructions. Each participant still received the standard discharge
instructions, to include review of action and side effects of their home medication list and
teaching on any other comorbidities. The $5.00 gift card given to each participant who
completed the in hospital part of the study and when the 30 day follow-up was completed
by phone, was acknowledged by many participants as an incentive to enroll and
participate in the study. Despite the gift card, partly given as an incentive and
acknowledgement of respect for participants’ time, there were a large number of
dropouts. Consideration should be taken in providing follow-up education and evaluation
of QOL done as part of a post hospital office visit instead of a phone call.
Selection of a QOL questionnaire with fewer questions may be more useful in this
critically ill patient population. Presenting the outcomes of the qualitative and
quantitative findings from this research will be communicated to administration, in order
to gain approval for the action plan to be used as an approved institutional discharge
procedure for patients with COPD.
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Limitations
Throughout the study it was noted that almost all the participants would ask to
have the study commence right after they agreed and signed the consent. Subsequently,
most of the trained PCU nurses were not immediately available to administer the
instructions from the action plan, except in one case. This is due to patient priorities on
this busy PCU. One of the three trained nurses was available to deliver the COPD
modified action plan and the PI completed the QOL questionnaire. Overall, there was a
lack of retention in 30 day follow up. Despite the PI calling participants, at their
requested time (sent on 14 day postcard with a date) and sometimes twice, to answer the
follow up questions, they either did not answer the phone or a message was left or they
did not want to complete the survey and QOL questionnaire. One participant stated on
the second call back, “I don’t feel well right now, please call back.” In some case there
was no answer and a message was left, with no return call from the participant or a
recording was given that the phone was no longer in service. During the 30 day followup phone calls to participants, few comments were obtained. Participants would simply
answer the questions repeated from the WHOQOL-BREF and the additional 6 questions
on satisfaction with the discharge education. For this reason only 10 verbal responses
were available for the question on satisfaction of the COPD instructions. Selection of a
QOL questionnaire with fewer questions may be more useful in this critically ill patient
population. Also, participants were sent hospital addressed stamped envelopes to return
the completed calendars, from which only two calendars were returned. Minimal
compliance to completing the calendar from participants is likely due to their impaired
condition from COPD and other coexisting conditions. Adding more tasks for the
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participants to do beyond self-assessing their respiratory symptoms was apparently not a
reasonable expectation. Due to the small sample size on follow-up and the specific
patient population being those with COPD hospitalized on a PCU, there is limited
generalizability for applicability of the findings.  
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Conclusions
This feasibility study establishes the ground work toward implementation of the
ALA modified COPD Action Plan to be used for discharge instructions teaching selfmanagement skills to patients with COPD in the acute care setting. Based on findings
from various studies reported in the literature on COPD action plans or education, there
are inconsistencies in their use, with mostly no specific information given on the content
of instructions, while some included pharmacological (steroids and antibiotics) and
nonpharmacological (pursed lip breathing) self-treatment for worsening respiratory
symptoms. The literature has little evidence in examining the use of COPD action plans
on patients in the acute care setting with high acuity, high risk populations, and those
with comorbidities. In addition, reports of findings from researchers revealed
inconsistent results of improvement on QOL following implementation of selfmanagement instructions (Choi, Chung & Han, 2014). Many of the studies were
conducted on those in the outpatient setting or after discharge with stable COPD or
patients with COPD but not having other major comorbidities such as cardiac disease,
making this feasibility study unique and challenging (Labreque et al., 2011; Ko, et al.,
2016, Trappenburg et al., 2011). The PCU participants were found to have ‘some high
school’ education (35%), majority were single (56%) and those not employed were
(84%). City Data (2015) reports the population where this study was conducted, has the
lowest income level in the state. Therefore, the SEM used as the theoretical framework
for this study provided a sound platform for developing this study and bringing to light
the factors impacting this population with COPD.
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The principle-based concept analysis of inflammation involving COPD
manuscript and the integrative review of instruments measuring risk factors predicting
hospital admission manuscript for patients with COPD created a closely linked scholarly
look at COPD in its complexity and highlighted the areas in need of future research.
Evaluation of QOL following administering discharge instructions needs to be
included, with consideration of alternate follow-up contact such as meeting participants at
office visits or clinic visits. Future studies are needed to examine outcomes using a larger
sample size, to include other hospital units and compare a different COPD action plan.
Comparison of two different COPD action plans would be necessary to include in the
study design ethically, because standard of care prior to this study did not include any
written COPD action plan for patients. Delivering a structured individualized action plan
may help overcome stumbling blocks that includes, lack of specific written instructions to
teach patients self-management of their COPD and a copy for the patient to take home.
Lessons Learned and Next Steps
The modified COPD Action Plan was well received by the findings from
participants who completed the 30 day follow-up survey. Participants reported no
readmissions for AECOPD (or COPD) on follow-up. No significant changes were found
in comparison of the mean domain scores from the WHOQOL-BREF questionnaire.
There were several limitations observed in this study, one being a large dropout of 34
participants after discharge, indicating a lack of retention and thus, poor follow-up. A
shortfall in follow-up after discharge from the hospital was likely related to moderator
variables, primarily severity of COPD (primary admitting diagnosis acute respiratory
failure (10, 20%) and socioeconomic factors (City Data, 2013). The other limitation was
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participants requested the instructions from the action plan and QOL questionnaire be
administered soon after they were enrolled. Trained PCU nurses were most of the time
not available to provide the action plan instructions. Since the study was conducted on a
PCU, the results are limited in generalizability to other patient populations.
Lessons learned from this study is that the patient population with COPD
receiving care on the PCU are critically ill and have little reserve, physically (dyspnea,
weak) and psychologically (anxious, depressed) that could have impacted adherence to
follow-up. Participants were eager in general to receive education from the modified
ALA COPD Action Plan and had little difficulty giving accurate teach-back of the zones
and appropriate action to take. Some participants asked for alternative resources if they
could not get an appointment with their physician when they felt their respiratory
symptoms worsening. This was an opportunity to inform participants of alternative
resources, for example to seek care from urgent care centers located near their homes.
Even though there were limitations, this feasibility study contributes to evidence that
providing education to patients with COPD in the in the acute care setting is beneficial.
Improvements in follow-up included reduced ED visits for COPD and empowerment of
patients gaining knowledge in identification of changes in respiratory symptoms, as
evidenced by patient satisfaction scores. Benefits of implementing self-management
COPD instructions in the acute care setting include patients making the connection of a
change in their respiratory symptoms and the need for hospital care. In some cases,
family or friends were available to be included in the instructions was another benefit.
This study gained support from nursing colleagues, who were eager to contribute by
carrying out this research intervention. The next step is to obtain funding to conduct a
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larger randomized clinical trial with multiple hospital units to compare implementation of
the modified ALA COPD Action Plan and another COPD action plan and include followup with participants during scheduled office visits.
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Table 1. Inclusion and Exclusion Criteria
Inclusion  
  
Adults  18  years-‐of-‐age  and  older  
Discharged  to  self-‐care,  home  (independently  or  with  
family/significant  other)  
Primary  or  secondary  diagnosis  of  exacerbation  of  COPD  
(ECOPD),  J44.1  International  Classification  of  Disease  
(ICD-‐10)  (2011)    
Score  of  15  on  the  Glasgow  Coma  Scale  
Understand  and  speak  English  
Have  access  to  a  working  phone  
Have  an  address  to  receive  mail  

Exclusion  
  
Patients  with  a  tracheostomy,  not  able  to  talk  or  
communicate  
Using  BiPAP  (noninvasive  bi-‐level  positive  airway  
pressure  ventilation)  during  the  day  or  on  mechanical  
ventilation  
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Table 2. American Lung Association – COPD Action Plan
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Table 3. 30 Day Follow-Up Calendar
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Table 4. PCU Nurse Evaluation on COPD Action Plan
1.   PCU nurses rate acceptability and ease of
delivery of action plan:
2.   Fits in with discharge instructions
normally given to patients, please rate:

3.  

(3) High _______
(2)Moderate _______
(1)Low________
a.   Good, fits into routine of patient care (3)
b.   Somewhat of an added burden to deliver to
participant (2)
c.   An imposition to daily nursing activities (1)

How much time to deliver action plan?
a.   10 minutes
b.   15 minutes
c.   25 minutes

4.   Do you see this teaching plan as a benefit
for future patients with COPD?

  

a.   Yes
b.   No
c.   c. Somewhat
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Table 5. Demographics Characteristics of Participants on PCU
	
  
Minimum

Maximum (Mean+/-SD)

49
Descriptive
Female 26 (52%)
AA (African American or
Black)
W (White)
Yes 19 (39.6%)
Yes 19 (38%)
Minimum 13.9
Single
Married
Divorced
No
Yes
Some high school
Some college
Completed college
Graduate school
No
Yes

84 (64.5/9.5)
Frequency/Percent
Male 24 (48%)
18 (36%)

Primary diagnosis
International Classification of
Diseases- 10th revision (ICD-10)
Acute respiratory failure J96.20
Acute exacerbation of COPD (AECOPD)
J44.1
Healthcare-Associated Pneumonia
(HCAP) J18.9
Acute and chronic respiratory failure
J96.20
Acute on chronic respiratory failure
J96.22
Exacerbation of COPD (ECOPD) J44.1
Secondary diagnosis
COPD J44.9
Exacerbation of COPD (ECOPD) J44.1
Acute exacerbation of COPD (AECOPD)
J44.1

Frequency

Percent

10
4

20%
8%

4

8%

3

6%

3

6%

3

6%

19
13
7

38%
26%
14%

Hypoxia R09.02

2

4%

Age in years (n = 50)
Gender
Race
Smoker
Home oxygen
Body Mass Index (BMI) Kg/m2
Marital Status
Home support
Education

Employed

32 (64%)
No 29 (60.4%)
No (62%)
Maximum 70.0 (24.4/11.4)
28 (56%)
17 (34%)
5 (10%)
14 (29.2%)
34 (70.8%)
34(69.4%)
10(20.4%)
4 (8.2%)
1 (2.0%)
41 (83.7%)
8 (16.3%)
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Table 6. RE-AIM: Results to Determine Feasibility of Study
RE-AIM Dimension
Reach
Feasibility to recruit predetermined goal
sample size of PCU participants (n =
50).

Effectiveness (measured by outcomes
and perception of benefit)
Participants’ perceived benefits of the
COPD Action Plan, on 30 day follow up
(survey and qualitative results).

Measurements
-Initial recruitment (n =50) in hospital
and total of 37 dropouts.

-Based on qualitative comments from
participants, three themes emerged from
the comments.

-Rated questions on satisfaction with
discharge protocol by participants

-Trained nurse. The COPD Action Plan
One trained PCU nurse completed a
questionnaire of rated and perceived
benefit of the discharge intervention for
participants with COPD.

Adoption
Individuals willing to implement
discharge instructions (one setting)
Rated responses and 30 day outcomes
of health care utilization and QOL
outcomes

-QOL results determined no significant
change in domain scores. Table

-Participants scores/ g satisfaction

  

Results/Comments
Diagram 1.
-Retention:
(n = 13) completed in-hospital study
-30 day follow up via phone calls (n =
13), this attrition was attributed in part
to the impaired condition of the
participants from COPD, comorbidities,
as well as socioeconomic factors.
1. Perceptions about Delivery of COPD
Action Plan reflected an appreciation of
knowledge gained, two responses,
“Person to person is always good” and
“No one (before) took the time to go
over this with me. I appreciate it.”
2. Based on participants feeling better
related to Improved Self-Management
Skills with a participant stating, “Doing
exceptionally well. Eating healthy and
stopped smoking” and another “Great.”
3. Consequences of Decline related to
COPD, “When real hot out, slow deep
breaths still don’t help.”
Do you think the discharge COPD Action Plan
taught you to better take care of your
respiratory symptoms and when to seek help?
(n = 13)
Yes = 12 (92.3%)
No = 1 (7.7%)
Gave moderate rating for acceptability
and ease in delivery of the action plan
(need to accommodate level of
comprehension for each patient).
Wilcoxon signed-ranks test of median
QOL scores indicated no statistical
significance among domains (score of
differences between means in hospital
and 30 day follow-up:
Physical
+1.4
Psychological +4.8
Social
-1.3
Environment -2.4
Rate satisfaction with COPD Action
Plan and delivery:
High = 4 (30.8%)
Moderate = 9 (69.2%)
Low = 0 (0%) Health care utilization st
hospital, 30 day follow-up:
Number of Emergency Department
Visits:
12 (99%) no ED visits
1 (1%) ED visits for insulin reaction
Number of Hospitalizations:
12(99%) no hospitalizations
1(1%) hospitalized 2 days, COPD
Number of times called #911 since
discharge:
0 (100%) none
Number of office visits:
5(40%) no visits
7(55%) scheduled visits
1(5%) problem (not COPD related)
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RE-AIM Dimension

Measurements

Results/Comments
30 day follow-up calendar, 2 were
returned completed with the following
results: Participant (1): green was
marked for good day = 93% (28 days
out of 30 total days recorded), yellow
marked for some problems breathing =
7% (2 days out of 30) and 3% (2 days
out of 32, nothing was recorded).
Participant (2): green marked = 64% (18
day out of 28 total days recorded),
yellow marked = 36% (10 days out of
28).

-Trained PCU nurse scores/ratings

Implementation
Consistency in delivery (fidelity) of the
COPD discharge procedure, feedback
from participants, and the nurse’s
recommendations.

-Trained PCU nurse score supported
implementation (based on one delivery
of action plan).

-Observed consistency in delivery
(fidelity) of the COPD discharge
procedure
Maintenance	
  
Determined	
  following	
  completion	
  of	
  
this	
  study,	
  based	
  on	
  quantitative	
  and	
  
qualitative	
  results	
  of	
  the	
  COPD	
  Action.	
  
	
  
Plan	
  as	
  an	
  approved	
  institutional	
  
discharge	
  procedure	
  for	
  patients	
  with	
  
COPD

  

-‐‑Results	
  will	
  be	
  submitted	
  to	
  hospital	
  
management.

Acceptance and ease of delivery of the
action plan, rated moderate.
Recommended each patient needs
individualized instruction based on their
knowledge level. “Fits in with discharge
instructions normally given to patients”
was given the highest rating ‘good’.
Do you see this action plan as a benefit
for future patients with COPD?
Response was ‘Yes’.
Length of time to deliver the action
plan” was scored ‘15 minutes’.
-Delivered COPD Action Plan per
scripted dialog, as observed by PI. Only
one trained PCU nurse was observed
due to limitation in availability of
nurses when participants enrolled to
receive discharge instructions.
-‐‑Clinical	
  manager	
  of	
  PCU	
  is	
  planning	
  
to	
  use	
  ALA	
  COPD	
  Action	
  Plan	
  on	
  unit.	
  
Use	
  of	
  the	
  action	
  plan	
  institutional-‐‑
wide	
  will	
  be	
  determined.	
  
	
  
-‐‑Obtain	
  grant	
  funding	
  to	
  compare	
  
ALA	
  COPD	
  Action	
  Plan	
  and	
  another	
  
action	
  plan	
  in	
  a	
  randomized	
  study	
  
done	
  o n	
  multiple	
  units	
  in	
  the	
  hospital.
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Table 7: 30 day Follow-up Phone Interview with Participates
1.   Do you think the discharge COPD Action Plan taught you to better take care of
your respiratory symptoms and when to seek help?
Comments:
Yes:
No:
2.   Level of satisfaction with delivery of COPD Action Plan.
(3)Highly satisfied ___ (2) Moderate satisfaction ___ (1) Low satisfaction___
3.  
4.  
5.  
6.  

Number of ED visits:
Number of hospital admission in the last 30 day after discharge:
Number of office visits: scheduled
unscheduled
WHOQOL-BREF questionnaire administered:

Table 8: WHOQOL-BREF Domain Scores

In hospital

In hospital
(sample
with
follow-up
only)

30 day
follow-up

N = 13

N=13

Mean
±SD
(Median)

Mean ±SD
(Median)

Mean ±SD
(Median)

Physical
domain score

49.3 ±16
(50.0)

54.4 ±15.6
(57.1)

55.8 ±21.4
(53.6)

Psychological
domain score

64.8±16.7
(66.7)

66.0 ±17.1
(66.7)

Social
Relations
domain score

60.0±20.3
(66.7)

Environment
domain score

70.2±14.6
(71.9)

N = 49

p values*

95%
Confidence
Interval

Z
Score*

+1.4 ±14.3

(-7.3, 10.0)

-.28

p = .78

70.8 ±18.9
(79.2)

+4.8 ±16.8

(-5.4, 15.0)

-.85

p = .40

57.1 ±18.3
(58.3)

55.8 ±21.4
(50.0)

-1.3 ±17.6

(-11.9, 9.4)

-.27

p = .79

74.8 ±12.2
(78.1)

72.4 ±12.4
(68.8)

-2.4 ±13.5

(-10.6, 5.8)

-.54

p = .59

Mean
(Median) SD

Difference
Between inhospital
means and
30 day
follow-up

Test
statistic

N= 13
Mean ±SD

*Wilcoxon Signed Ranks Test
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Figure 1. Postcard: Reminder of 30 Day Follow-Up Phone Call
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Appendix I: American Lung Association: License Agreement
  

LICENSE AGREEMENT
This License Agreement is between American Lung Association (“ALA”), with its
principal place of business at 1301 Pennsylvania Avenue NW, Suite 800, Washington,
DC 20004 and Patricia Conley, RN MSN PCCN/Medical University of South
Carolina/Research Medical Center (“You”). You have asked for permission to use
certain materials owned by ALA in your research project or study. ALA grants your
request subject to the following terms and conditions. Your signature below indicates
your agreement to comply with all the terms and conditions outlined below.
Nature of Research Project or Study (the “Study”):
Chronic Obstructive Pulmonary Disease (COPD) discharge action plan and perception of
quality of life issues (QOL). The research study is part of my PhD program of study at
the Medical University of South Carolina, School of Nursing.
ALA Materials to be Use in the Study:
•   COPD Action Plan
Reference
American Lung Association. (2013). http://action.lung.org/site/DocServer/actionmanagement-plan.pdf. (Retrieved 8/30/2015).
How the ALA Materials will be Used in the Study:
The COPD Action Plan (ALA, 2013) will be used to in a research study as part of a
discharge instruction guide presented verbally to each patient in the privacy of their
hospital room. Also, each patient will be given a copy of the Action Plan to take home.
The study and this ALA Action Plan will need to be approved for use by the Institutional
Review Board at the Medical University of South Carolina and Research Medical Center.
Time Period for Use of ALA Materials:
The time period could be estimated 12 months (September, 2016 to September, 2017).
Your Contact Information (Name, Title, Address, Phone and Email):
Patricia Conley, PhD Student
10017 E. 68th Terrace
Raytown, Missouri 64133
Cell: 816-509-2676 and Home: 816-356-9863
conleyp@musc.edu
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Appendix II: Institutional Review Board Letter ofAppendix
ApprovalII:
Institutional  Review  Board  for  Human  Research  (IRB)  
Office  of  Research  Integrity  (ORI)  
Medical  University  of  South  Carolina  
  
Harborview  Office  Tower  
19  Hagood  Ave.,  Suite  601,  MSC857  
Charleston,  SC    29425-‐8570  
Federal  Wide  Assurance  #  1888  
APPROVAL:  

  

  

  

  

  

  

  

  

This  is  to  certify  that  the  research  proposal  Pro00051799  entitled:  
Structured  COPD  Discharge  Education  and  Quality  of  Life:  A  Feasibility  Evaluation        
  

Submitted  by:  Patricia  Conley  

  

Department:  Medical  University  of  South  Carolina  

for  consideration  has  been  reviewed  by  IRB-‐I  -‐  Medical  University  of  South  Carolina  and  approved  with  
respect  to  the  study  of  human  subjects  as  adequately  protecting  the  rights  and  welfare  of  the  individuals  
involved,  employing  adequate  methods  of  securing  informed  consent  from  these  individuals  and  not  
involving  undue  risk  in  the  light  of  potential  benefits  to  be  derived  therefrom.    No  IRB  member  who  has  a  
conflicting  interest  was  involved  in  the  review  or  approval  of  this  study,  except  to  provide  information  as  
requested  by  the  IRB.  
Original  Approval  Date:  3/28/2016  
Approval  Expiration:  3/27/2017  
Type:  Expedited  
Chair,  IRB-‐I  -‐  Medical  University  of  South  Carolina  
Mark  Hamner*  
Statement  of  Principal  Investigator:  
As  previously  signed  and  certified,  I  understand  that  approval  of  this  research  involving  human  subjects  is  
contingent  upon  my  agreement:  
1.   To   report   to   the   Institutional   Review   Board   for   Human   Research   (IRB)   any   adverse   events   or  
research  related  injuries  which  might  occur  in  relation  to  the  human  research.    I  have  read  and  will  
comply  with  IRB  reporting  requirements  for  adverse  events.  
2.   To  submit  in  writing  for  prior  IRB  approval  any  alterations  to  the  plan  of  human  research.  
3.   To  submit  timely  continuing  review  reports  of  this  research  as  requested  by  the  IRB.  
4.   To  maintain   copies   of   all   pertinent  information   related   to   the  research   activities  in   this   project,  
including  copies  of  informed  consent  agreements  obtained  from  all  participants.  
5.   To  notify  the  IRB  immediately  upon  the  termination  of  this  project,  and/or  the  departure  of  the  
principal  investigator  from  this  Institution  and  the  project.  
  
*Electronic  Signature:  This  document  has  been  electronically  signed  by  the  IRB  Chairman  through  the  
HSSC  eIRB  Submission  System  authorizing  IRB  approval  for  this  study  as  described  in  this  letter.  

  

109  

Appendix III: Research Medical Center Approval
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Appendix IV: Consent Form
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Appendix V: HIPAA Form
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Appendix VI: Letter of Permission from Journal
RE: Inclusion granted

November 17, 2016

Dear Dr. Patricia Conley,
Warm Greetings!
Thank you for mail. Please proceed to include it. We apologize for the delay in response.
Please feel free to let us know for further assistance.
Regards,

Neil Jacobson
Jacobs Journal of Pulmonology
Jacobs Publishers
9600 Great Hills
Trail # 150w
Austin, Texas
78759(Travis County)
E-mail: pulmonology@jacobspublishers.international

  

121  

APPENDIX VII: Letter of Permission from the US WHOQOL Center
Thank you for your interest in the World Health Organization Quality of Life — BREF
US English Version Instruments.
We distribute the WHOQOL-BREF U.S. English Version free of charge as electronic
files.
Any questions can be directed to:
US WHOQOL Center
Attn: Instrument Distribution Coordinator
University of Washington, Department of Health Services
Box 359455
Seattle, Washington, USA 98195-9455
Phone: (800) 291-2193
Fax: (206) 616-3135
Email: seaqol@u.washington.edu

Although this information isn’t required, we would also appreciate a short description of
how you plan to use the instrument. The information would be used to enhance the
effectiveness of future instruments or revisions.
Sincerely,
Instrument Dissemination Coordinator, US WHOQOL Center
Name (First, Last, Title):
Patricia Conley, RN MSN PCCN
Today's Date:
09/15/2015
Organization:
Medical University of South Carolina
Mailing Address (Street, PO Box):
10017 E. 68th Terrace
City, State (if USA), Postal Code:
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Raytown, MO, 64133
Country (if outside USA):
Phone 1:
816-509-2676
E-mail:
conleyp@musc.edu
Study Name:
Feasibility Study of a COPD Discharge Protocol
Sample Population:
Hospitalized Critically Ill Patients
Estimated Sample Size:
30
Estimated Study Start and Completion Dates:
03/01/2015
Brief Description of Project:
The aim of the study in general is to evaluate the outcome of patients subjective score on
gained knowledge, hospital readmission,emergency room visits, and calls to the doctor.In
addition, the score of the patients self rating on quality of life (QOL) will be evaluated,
hoping that the discharge instructions will improve their perception of having a better
QOL.
User Agreement for the WHOQOL-BREF Instrument
Please read the following information carefully

The UNIVERSITY OF WASHINGTON distributes the WHOQOL-BREF and its
translations available in the following languages: U.S. English
Therefore, User and UNIVERSITY OF WASHINGTON agree as follows:
1.

UNIVERSITY OF WASHINGTON’s obligations

UNIVERSITY OF WASHINGTON shall deliver the original WHOQOL-BREF and/or
the translations requested by “User” subject to the following conditions:
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§ The translations requested are available, and
§ The present agreement is duly completed and signed by “User”
2.

“User”’s obligations

2.1 No modification
“User” shall not modify, abridge, condense, adapt, recast or transform the WHOQOLBREF in any manner or form, including but not limited to any minor or significant
change in wordings or organization in WHOQOL-BREF, without the prior written
agreement of UNIVERSITY OF WASHINGTON, which agreement shall not be
unreasonably withheld or delayed.
2.2 No translation
“User” shall not translate WHOQOL-BREF, without the prior written agreement of Dr.
Donald Patrick.

2.3 No reproduction
“User” shall not reproduce the WHOQOL-BREF except for the limited purpose of
generating sufficient copies for use in investigations stated hereunder and shall in no
event distribute copies of the WHOQOL-BREF to third parties by sale, rental, lease,
lending, or any other profit-making means.
2.4. Publication
In case of publication of study results, “User” shall cite (1) “Bonomi AE, Patrick, DL.,
Bushnell, DM, Martin M (2000). Validation of the United States' version of the World
Health Organization Quality of Life (WHOQOL) instrument. Journal of Clinical
Epidemiology, 53(1), 13-17.” in reference section of the publication. (New publications
may be added and older ones deleted).
2.5 Provision of data
All data, results and reports obtained by, or prepared in connection with the WHOQOLBREF shall remain the User’s property. However, UNIVERSITY OF WASHINGTON
may request the User to share data, results and reports obtained through the use of the
WHOQOL-BREF, which request User can accept or reject in its sole and unfettered
discretion. UNIVERSITY OF WASHINGTON shall ensure the anonymisation of such
data at three levels, by the removal of: any patient identification, any university or
company identification and any therapy name. UNIVERSITY OF WASHINGTON will
classify and reorganize such anonymous data and therefore, shall hold all intellectual
property rights regarding these data when and if submitted to the data pool.
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UNIVERSITY OF WASHINGTON may provide such reorganized data to third parties,
for analysis in education, research, consulting, and specifically for the evaluation of
cross-cultural equivalence and development of reference values for this WHOQOLBREF or for any other similar project.
2.6 Payment
2.6.1 Royalty fees (Authors)
The use of the WHOQOL-BREF is free of author’s royalty fees.
2.6.2 Distribution fees (UNIVERSITY OF WASHINGTON)
The use of the WHOQOL-BREF in studies is not subject to a distribution fee.

2.6.3 Invoicement
For the use of the WHOQOL-BREF, this completed user agreement shall suffice as
invoicement.
3. Copyright Infringement
The WHOQOL-BREF was developed by the World Health Organization at The
University of Washington. The World Health Organization holds copyright over the
WHOQOL and all its present and future translations. Each new translation will be made
available to third parties once it is available, through the World Health Organization,
under the conditions described in the present document.
If, at any time during the term of this agreement, « User » learns of any infringement by a
third party of any Intellectual Property Rights in connection with the WHOQOL-BREF,
« User » shall promptly notify UNIVERSITY OF WASHINGTON. UNIVERSITY OF
WASHINGTON shall notify such infringement to Authors. Authors will decide to
institute or not proceedings against the infringing party.
4. Confidentiality
All and any information related to the WHOQOL-BREF including but not limited to the
following: information concerning clinical investigations, creations, systems, materials,
software, data and know-how, translations, improvements ideas, specifications,
documents, records, notebooks, drawings, and any repositories or representation of such
information, whether oral or in writing or software stored, are herein referred to as
confidential information. Likewise, any information provided by User to Authors
relating to this Agreement, including information provided in this Agreement, shall be
treated as confidential information.
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In consideration of the disclosure of any such confidential information to the other, each
party agrees to hold such confidential information in confidence and not divulge it, in
whole or in part, to any third party except for the purpose specified in this agreement.
5. Use of name
It is agreed that UNIVERSITY OF WASHINGTON shall not disclose, whether by the
public press or otherwise, the name of “User’ or institution”, to any third party to this
agreement except to the copyright holder(s) of the WHOQOL-BREF.
6. Liability
6.1 In case of breach of contract
In the event of total or partial breach by UNIVERSITY OF WASHINGTON of any of its
obligations hereunder, UNIVERSITY OF WASHINGTON’s liability shall be limited to
the direct loss or damage (excluding loss of profit and operating losses) suffered by
“User” as a result of such breach and shall not include any other damages and particular
consequential damages.
6.2 In the scope of the use of the “Questionnaire”
Under no circumstances may Authors or UNIVERSITY OF WASHINGTON be held
liable for direct or consequential damage resulting from the use of the WHOQOLBREF.
6.3 In the event of non-renewal of this Agreement
In the event of non-renewal of this Agreement by UNIVERSITY OF WASHINGTON for
any cause or failure by UNIVERSITY OF WASHINGTON to conclude a new agreement
with “User” upon the expiry of this Agreement, UNIVERSITY OF WASHINGTON will
have no liability for payment of any damages and/or indemnity to “User”.
7. Term and termination
This agreement shall be effective as the date of its signature by “User” and shall continue
for a term of 10 (ten) years at least or until the term of the study above mentioned in
SUMMARY OF THE STUDY.
Either party may terminate this Agreement immediately upon providing written notice to
the other party in the event of: (a) the other party’s unexcused failure to fulfil any of its
material obligations under this Agreement or (b) upon the insolvency or bankruptcy of, or
the filing of a petition in bankruptcy or similar arrangement by the other party. User may
terminate this Agreement for any reason upon 90 days written notice.
Upon expiration or termination of this Agreement UNIVERSITY OF WASHINGTON
may retain in its possession confidential information it acquired from WHOQOL-BREF
while under contract. The obligations which by their terms survive termination, include,
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without limitation, the applicable ownership, confidentiality and indemnification
provisions of this Agreement, shall survive termination.
8. Assignment
This Agreement and any of the rights and obligations of “User” are personal to the
“User” and cannot be assigned or transferred by “User” to any third party or by operation
of law, except with the written consent of UNIVERSITY OF WASHINGTON notified to
“User”.
9. Separate Agreement
This Agreement holds for the above mentioned study only. The use of the WHOQOLBREF in any additional study of the “User” will require a separate agreement without
additional fees, unless significant updates have been added to the user manual (new
edition, etc.).
10. Entire Agreement, Modification, Enforceability
The entire agreement hereto is contained herein and this Agreement cancels and
supersedes all prior agreements, oral or written, between the parties hereto with the
respect to the subject matter hereto.
This Agreement or any of its terms may not be changed or amended except by written
document and the failure by either party hereto to enforce any or all of the provision(s) of
this Agreement shall not be deemed a waiver or an amendment of the same and shall not
prevent future enforcement thereof.
If any one or more of the provisions or clauses of this Agreement are adjudged by a court
to be invalid or unenforceable, this shall in no way prejudice or affect the binding nature
of this Agreement as a whole, or the validity or enforceability of each/and every other
provision of this Agreement.
11. Governing law
This Agreement shall be governed by and construed in accordance with the laws of the
State of Washington. Any disputes will be adjudicated first through the UNIVERSITY
OF WASHINGTON and subsequently through courts in the State of Washington.
Acceptance of Terms of User Agreement:
I have read and agree to the terms listed in the user agreement above.
You have completed the user permission form for the WHOQOL-BREF and are now free
to download the instrument and scoring information at
http://depts.washington.edu/yqol/WHOQOL-BREF
Thank you for your interest in the WHOQOL-BREF!
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